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ABSTRACT 
A previous discovery showed that a spontaneous mutant in the aroD gene of the RNAi 
bacteria HT115(DE3), caused a significant increase in C. elegans longevity. In this 
thesis, I aimed to confirm this finding and attempt to determine whether chemical 
inhibition of folate synthesis in other E. coli strains would also increase C. elegans 
lifespan, and uncover the mechanism via which inhibited folate synthesis increases 
animal lifespan. 
In order to confirm that the aroD mutant E. coli increase lifespan I investigated effects 
of using different media types. Data show that the aroD mutant E. coli shows variable 
effects on C. elegans lifespan with different media types due to the varying folate 
content of media used. I found that the aroD mutant E. coli effect on lifespan was 
maximal using a high purity agar with peptone. I then attempted to mimic the effect 
on other E. coli bacterial strains, such as OP50 commonly used as the E. coli food 
source for C. elegans, by using sulfamethoxazole as a chemical intervention to inhibit 
folate synthesis. Sulfamethoxazole increased C. elegans lifespan in a dose dependent 
manner. Interestingly, even though SMX is used as an antibiotic, the highest 
concentration used did not appear to decrease growth of the E. coli lawn substantially. 
Liquid chromatography coupled to mass spectrometry was used to measure and 
confirm the folate levels in both E. coli and C. elegans. 
In order to uncover the specific mechanism by which inhibition of folate synthesis 
increases C. elegans lifespan, I needed to distinguish whether folate status of E. coli 
itself, folate status of C. elegans, or an interaction of folate status in both organisms 
was responsible for the increase in lifespan. The drug methotrexate (MTX) and the C. 
elegans gcp-2.1 mutant were used to investigate the effect of inhibiting the worm 
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folate cycle, and impeding animal folate uptake. Results suggest that animal folate 
status does not play a role in the extended longevity. SMX and kanamycin have 
similar but not additive effects on lifespan, suggesting a common mechanism for both 
drugs. This is surprising as kanamycin prevents bacterial proliferation, whilst SMX 
does not. Bacterial accumulation assays suggested that bacterial accumulation may be 
a marker of ageing not a cause in this system. 
Together the data presented here show that it may be possible to use chemical 
interventions to treat the mammalian gut flora, inhibiting excessive microbial folate 
synthesis and potentially slow ageing, without disrupting microbial ecology.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Overview 
Ageing is something that we have all felt the effects of, either in ourselves or in loved 
ones. Researchers in the field of ageing have suggested many different theories and 
ideas about why we age, and the direct causes of ageing. Implications have been made 
about the importance of diet and the role of gut microbes in many chronic diseases 
and ageing. Gut microbes provide animals with essential nutrients and vitamins that 
animals themselves cannot synthesis, such as folates.  
 
The well characterised model organism Caenorhabditis elegans has long been used 
for the study of ageing, due to its short lifespan and ease of maintenance. In the 
laboratory, C. elegans is maintained on lawns of Escherichia coli. Together these two 
model organisms provide a system in which interactions between host and microbe, 
and also the effect of diet on health can be more closely studied. 
 
1.2 Why do we age?  
Many people do not consider ageing as a disease, but rather something inevitable that 
happens to all of us after a certain period of time. As people grow older, they notice 
changes in the way in which their bodies work, a decrease in fertility, muscles weaken, 
and bones become more prone to fracture. Along with these changes the risks of 
getting certain diseases such as cancer and diabetes increases with age, as does 
mortality (Kirkwood & Austad 2000). It is not just humans that age, almost all 
organisms and biological systems show deleterious effects of ageing or senescence, be 
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it tissue degradation or loss of normal functionality or efficiency. However, there are 
some exceptions, species that do not appear to show signs of increased mortality or a 
reduction in fertility with increasing age, such as Hydra, suggesting that ageing is not 
a trait that effects all organisms (Finch 1994; Kirkwood & Austad 2000). Not all 
species age gradually either, the Pacific salmon ages all at once after their one chance 
of reproduction in life has passed, this is thought to be driven by sex hormones 
(Kirkwood 2008).  
 
1.3 Evolutionary theories of ageing 
If some organisms do not show any apparent signs of ageing, this implies that ageing 
is not a universally programmed trait (Kirkwood & Austad 2000; Kirkwood 2005). 
With such negative effects on individuals, the question arises as to why ageing would 
evolve at all. The field of ageing research is vast, and much work has gone into trying 
to determine why and how ageing has evolved. Understanding why ageing has 
evolved, provides us with an insight to the nature of the genes that are involved in the 
ageing process, and how they can shape the relationship between reproduction and 
survival in life history (Kirkwood 2008). It has been suggested that the diversity of 
life history patterns observed in nature, is an effect of natural selection not being 
strong enough to control intrinsic deterioration of the body (Kirkwood 2005; 
Kirkwood 2008).  
 
In the literature there are three main theories regarding the evolution of ageing. The 
mutation accumulation theory first suggested by Medawar, suggests that the selective 
force on individuals progressively decreases with age. Therefore in a wild population, 
by an age when survival levels have become extremely low, the selective pressures on 
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the few surviving individuals has also become very weak. The selective force at this 
late stage is too weak to act against any germ-line mutations that have deleterious 
effects later in life. This may then act to delay the onset of such deleterious alleles to 
ages where they would have very little selective pressure to purge them. High levels 
of extrinsic mortality would suggest early reproduction to be beneficial, and after 
reproduction there would be little or no selective pressure on deleterious effects later 
in life. (Medawar 1952; Kirkwood & Austad 2000; Kirkwood 2005; K irkwood & 
Melov 2011).  
  
Williams then further developed Medawar‟s theory and suggested that pleiotropic 
genes that had positive effects early in life would be selected for even if they exhibited 
deleterious effects later in life, as selective pressure is theoretically stronger earlier in 
life (Williams 2001; Kirkwood & Austad 2000; Kirkwood 2005). As fitness can be 
assessed by magnitude of the effect and by the probability of surviving to be affected, 
then a small benefit earlier in life may be selected for in spite of a late acting 
significantly negative effect. This theory is known as the antagonistic pleiotropy 
theory (Kirkwood & Austad 2000).   
 
Although the mutation accumulation and antagonistic pleiotropy theories have been 
well established in the literature with regards to evolutionary theories of ageing, there 
is little positive evidence, and much evidence to the contrary with regards to the 
feasibility of mutation accumulation (Kirkwood & Austad 2000; Kirkwood 2008). A 
Drosophila study by Service et al suggested that mutation accumulation may act 
alongside trade-offs (Service et al. 1988).  
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Other studies on Drosophila appeared to provide evidence and support for mutation 
accumulation (Hughes & Charlesworth 1994; Charlesworth & Hughes 1996), however 
further research has raised doubts (Promislow & Tatar 1996; Shaw et al. 1999). With 
respect to the antagonistic pleiotropy theory there have been relatively few confirmed 
individual genes that have been shown to have the type of antagonistic pleiotropy 
originally proposed by Williams (Leroi et al. 2005; Kirkwood & Melov 2011). 
 
The third theory for the evolution of ageing is the disposable soma theory, which 
looks at the optimal allocation of metabolic resources, mainly energy, between 
reproduction and somatic maintenance for maximum Darwinian fitness (Kirkwood 
1977; Kirkwood & Holliday 1979; Kirkwood & Austad 2000; Kirkwood 2005). The 
theory suggests that in the wild, somatic maintenance is required to keep the 
individual in appropriate physiological condition as long as the individual has a good 
chance of surviving unfavourable conditions. An example of this can be found in wild 
mice. Approximately 90% of wild mice die in the first year; therefore investment of 
energy into mechanisms for survival beyond this age will only benefit 10% of the 
population. Almost all of the processes needed for somatic maintenance, including 
DNA repair, require a high amount of energy. The main cause of death in mice is the 
cold in winter; mice are unable to maintain thermogenesis showing that resources are 
limited. The disposable soma theory suggests that the mouse will benefit by allocating 
any spare resources into thermogenesis, rather than repair or reproduction. If this were 
to happen, then the lack of somatic repair would lead to an accumulation in damage 
leading to ageing (Kirkwood & Austad 2000; Kirkwood 2005). The disposable soma 
theory focuses on the evolution of optimal levels of cell maintenance, and makes 
specific predictions about the biology of ageing. One prediction is that ageing results 
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from lifelong accumulation of unrepaired molecular and cellular damage through 
evolved limitations in repair functions and somatic maintenance. Other predictions are 
that longevity is controlled in principle by genes that regulate levels of somatic 
maintenance and repair functions, and that immortality of the germ line may require 
higher levels of maintenance and repair in germ cells as compared with somatic cells. 
Furthermore disposable soma predicts that the mechanisms behind cellular and 
molecular ageing are strongly influenced by chance. Also that the allocation of 
resources to repair and maintenance is determined by evolutionary optimization and 
the allocation strategy may need to be adaptive to respond to individual variations of 
circumstance during the organism‟s life cycle. These predictions help to bring a 
mechanistic specificity to the evolutionary theory of ageing (Kirkwood 2008).  
 
1.4 Mechanistic theories of ageing 
Evolutionary theories of ageing do not necessarily help us to understand the direct 
causes or mechanisms behind the ageing process. There are many changes in an 
individual that occur during the ageing process, reminding us how complex ageing is. 
This complexity has resulted in a plethora of theories that suggest specific cellular and 
molecular causes of ageing. There are too many theories of ageing to discuss in detail, 
a review in 1990 reported over 300 theories of ageing (Medvedev 1990). Here I will 
discuss a few of the more popular and key theories of ageing.  
 
1.4.1 Cellular senescence/Telomere loss theory 
In 1965 Hayflick found that almost all human cells have a limited number of cell 
doublings that they are capable of in culture (Hayflick 1965). This means there is a 
characteristic number of divisions before a cell enters a terminally arrested state 
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(Weinert & Timiras 2003; Kirkwood 2005; Campisi & Fagagna 2007). This led to the 
theory that this intrinsic limit also limits organism lifespan. This restriction on the 
number of divisions a cell can make is thought to be due to loss of telomeres during 
replication events (Harley 1991; Harley & Vaziri 1992; Levy et al. 1992; Olovnikov 
1996; Kirkwood 2005; Weinert & Timiras 2003). It has been suggested that immortal 
cell lines like germ line cells or stem cells express telomerase which acts to extend 
telomeres (Cech 2004). It is thought that senescent cells may create a hazardous 
environment and therefore may have an effect on neighbouring cells (Krtolica & 
Campisi 2002). A possible cause for this effect on neighbouring cells may be due to 
the fact that senescent cells have been shown to have higher expression of pro-
inflammatory cytokines (Weinert & Timiras 2003). Whilst the relevance of the 
hayflick limit to in vivo cellular senescence has been questioned (Rubin 2002), studies 
on baboons have shown that potentially more than 15% of skin cells in ageing animals 
are senescent (Herbig et al. 2006). This effect was not observed in muscle, indicating 
that perhaps the level to which senescent cells contribute to ageing differs by tissue 
and organism (Jeyapalan & Ferreira 2007).  
 
1.4.2 Oxidative stress theory 
Oxidative stress has long been thought to be involved in determining the rate of 
ageing (Harman, 1956). The theory suggests that ageing is caused by exposure to  
reactive oxygen species (ROS), which then leads to the oxidative damage in the cell, 
which accumulates with age. This links ageing to mitochondrial metabolism, since 
superoxide (O2
-) production by the electron transport chain is the greatest source of 
ROS in cells (Brand, 2000). Studies show that there are increased levels of oxidant-
damaged DNA and proteins in older cells (Harman 1992; Harman 1993; Beckman & 
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Ames 1998; Weinert & Timiras 2003).  Whilst there is convincing evidence showing 
that oxidative damage accumulates in ageing cells, it has not been shown that the 
oxidative damage is a direct cause of ageing. The oxidative stress theory seems to be 
consistent with the underlying idea that animals with fast metabolism live shorter than 
those with a slower one (the so-called “rate of living” theory). Selection of different 
metabolic rates in different organisms leads to different rates of O2
- production and 
therefore, different rates of ageing (Gems, 2009; Sohal and Weindruch, 1996). 
However, this long-held view of a direct relationship between metabolic rate and ROS 
production is now seen as naïve, given the extent to which they are uncoupled (Brand, 
2000).  
 
The effects of the superoxide dismutase (SOD) mimetics EUK-8 and EUK-134, which 
catalyze the disposal of O2
- on C. elegans lifespan, have been investigated (Gems and 
Doonan, 2009). It was found that 2mM paraquat shortens lifespan and generates O2
- 
and that certain concentrations of EUK-8 can rescue this shortened lifespan. These 
same concentrations of EUK-8 however, are not capable of extending lifespan in the 
absence of paraquat. This strongly suggests that O2
- levels do not limit worm lifespan 
in usual conditions (Keaney et al., 2004). Treatment with higher doses of SOD 
mimetics actually shortens C. elegans lifespan and EUK-8 has also been shown to 
cause increases in oxidative damage in E. coli (Gems and Doonan, 2009). It is 
possible that strongly increased SOD activity actually increases overall ROS by 
increasing levels of H2O2 (Buettner et al., 2006). 
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1.4.3 Gene regulation theory 
The gene regulation theory of ageing suggests that senescence is due to a change in 
gene expression with age. Microarray studies have shown that the expression of many 
genes change with time (Reinke 2002; Weinert & Timiras 2003). Microarrays allow 
researchers to create a genetic profile of model organisms, which can then be used as a 
comparison for interventions that may slow or promote the ageing process. This type 
of research, at the level of the genome, may lead researchers to key genes in which 
changes in expression level play a role in the ageing process, thus providing detail 
about specific mechanisms behind senescence (Weinert & Timiras 2003). Microarray 
studies have been used to examine gene expression in mice, with results showing very 
little variation in gene expression in some tissues of ageing mice (Weindruch et al. 
2001; Weindruch et al. 2002). 
 
1.4.4 Somatic mutation theory 
 It has been shown that the rate of DNA mutation in somatic cells is much higher than 
in gametic cells (Curtis 1963). It has also been suggested that the rate of spontaneous 
somatic cell DNA mutation increases with age (Kirkwood 2005). These somatic 
mutations can accumulate with time, and it has been shown that there are larger 
amounts of DNA damage in older individuals (Vijg 2000). It is yet to be determined 
however, whether the accumulation of such mutations can cause a large enough effect 
to cause ageing.  
 
Mice have been cloned for six generations using somatic nuclear transfer, without 
showing any apparent effects on their rate of ageing (Wakayama et al. 2000). This 
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study suggests that in mice at least, somatic mutation accumulation is not enough to 
impact ageing  
 
1.4.5 Theories of systematic ageing 
The theories of ageing mentioned above specify a cellular or molecular level cause of 
ageing. However there are a number of theories of ageing at the individual (organism) 
level. One example of this in humans is the neuroendocrine theory of ageing. In this 
theory of ageing, it is hypothesised that changes in neural and endocrine system 
functions, including communication and responsiveness of body systems to external 
stimuli and maintenance of optimal functional state can be detrimental. Another 
theory of ageing at the organism level is the rate of living theory of ageing. This 
theory is based on the assumption that an individual has a fixed amount of metabolic 
potential that is available for use throughout life. In this case the faster yo u use the 
metabolic resources the faster you senesce, this theory is also known as the live fast, 
die young theory of ageing (Weinert & Timiras 2003)  
 
1.5 Dietary Restriction 
There has been much research providing evidence that it is possible to alter the rate of 
ageing using specific interventions. One of the most widely known interventions is a 
type of diet manipulation referred to as dietary restriction (DR). Many studies have 
shown that restricting diet without malnutrition not only extends lifespan, in some 
cases a 50% increase has been observed, but it has also been shown to reduce the 
occurrence of age-dependent diseases in almost all species.  
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Research shows that there are many methods of inducing DR in C. elegans (Lenaerts 
et al. 2008; Greer & Brunet 2009). It is not known currently, whether the different 
methods of DR extend lifespan through a single common pathway or whether there 
are independent mechanisms that are activated, dependent on the method used (Greer 
& Brunet 2009).  
 
In many organisms, DR appears to increase lifespan in part by down-regulating the 
nutrient sensor TOR (Target of Rapamycin). Inhibition of TOR elicits autophagy, the 
recycling of cytoplasmic molecules and organelles (Hansen et al. 2008). A study by 
Hansen et al found that DR and TOR inhibition in C. elegans produce an autophagic 
phenotype. Further, inhibiting genes required for autophagy prevents DR and TOR 
inhibition from extending lifespan, and despite the rejuvenating effect that autophagy 
is predicted to have on cells, data show that autophagy is not sufficient to extend 
lifespan (Hansen et al. 2008). 
 
In C. elegans AMP-activated protein kinase (AMPK) is activated by a decrease in 
energy levels, raising the possibility that AMPK may mediate lifespan extension by 
DR (Greer et al. 2007). Research has shown that AMPK exerts its effects in part via 
the FOXO transcription factor DAF-16. FOXO/DAF-16 is required for the positive 
effects of this DR method on lifespan. Data show that expression of active AMPK in 
C. elegans increases stress resistance and extends longevity in a FOXO/DAF-16 
dependent manner (Greer et al. 2007). 
 
DR is often termed caloric restriction (CR) where calorie intake is restricted regardless 
of the food source (carbohydrate, protein and fat) rather than limiting food as in DR. 
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This is the case with regards to rodents because daily calorie intake rather than food 
type has been suggested to be the key determinant of lifespan. This hypothesis 
resulted from the findings that calorie restriction without reducing protein intake 
increased lifespan, and also no lifespan extension was observed when rats were fed 
isocaloric diets with reduced fat or minerals (Mair et al. 2005). However in other 
experiments, rats fed isocaloric diets with altered nutritional composition showed 
lifespan extension (Mair et al. 2005). Hence, it seems that reducing the level of 
ingested calories may not always be critical for life-span extension by DR in rodents.  
 
CR has also been shown to have beneficial effects in non-human primates. A study 
reported the beneficial effects of a 30% CR in female and male rhesus macaques of a 
wide age range. Results are similar to that of rodent studies where body weight and fat 
mass are both reduced, and blood lipids, blood pressure and body temperature are all 
decreased. These findings could be indicative of a longer lifespan, the study is 
ongoing (Mattison 2003).  
 
1.6 Diet and ageing  
Dietary restriction is one method that has been shown to increase lifespan of animals. 
There is much literature to provide evidence that diet can affect lifespan, for example 
the longest living national population are the Japanese, and this is thought to be down 
largely to their healthy diet of rice, fish and vegetables and lifestyle choices. 
Controlling ones diet is an option available to many of the world‟s population.   
 
There is a multibillion dollar market for vitamins and health supplements in the US 
and increasingly so in the UK with the goal of improving human health. Such 
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supplements claim to increase both lifespan and health, yet none of them have 
provided substantial evidence to support the claims that they extend lifespan.  
 
Investigating the relationship between diet and ageing in animals is difficult due to 
many confounding variables. Factors that affect ageing include environmental factors, 
complexity of an organism‟s diet and the heterogeneity of the microbiota present in 
the gut of animals. All wild individuals have different environments to each other. An 
example in the human population is the difference between an eastern or western diet. 
An individual‟s genetics can also have an effect on the role that diet can play with 
regards to health. There is evidence to show that Asian immigrants have between a 
four –fold and six- fold  increase in diabetes dependent on country of birth, and a 
increased susceptibility to cardiovascular type II disease compared to Caucasians 
(Barnett et al. 2006; Cappuccio 1997; Cappuccio 1998). This increased risk of disease 
is observed in second generation migrants, suggesting that genetics is involved as 
these second generation immigrants have been shown to share the same risk factors as 
their parents and grandparent (Barnett et al. 2006).  
 
Most animals include a wide variety of foods in their diet and therefore the effect of a 
single dietary component is hard to distinguish from effects that other foods or 
combinations of foods are causing. Separating beneficial effects of diet on lifespan is 
therefore difficult due to the varying environment in which all organisms live and 
their genetic predisposition. Another important factor to consider is that  as well as 
food intake in animals, microbes in the gut of animals can also significantly contribute 
dietary components and nutrients.  
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1.7 Gut microbiota and human health 
In a human body microbes collectively make up 100 trillion cells, with the number of 
microbes in the gut lumen outnumbering all of the eukaryotic cells in the human body 
10 to 1 (Guarner & Malagelada 2003; Qin et al. 2010). Microbial flora have a 
symbiotic relationship with animals, in that the microbes assist nutrition by converting 
ingested food into accessible metabolites and also via the synthesis of essential 
compounds that animals cannot make themselves such as folic acid and can aid 
absorption of calcium, magnesium and iron (Miyazawa et al. 1996; Younes & 
Coudray 2001; Guarner & Malagelada 2003). In humans gut microbes also have 
important trophic effects on intestinal epithelia and on immune structure and function, 
and protection of the colonised host against invasion by alien microbes (Guarner & 
Malagelada 2003). Gut microbiota might also play an essential role in certain 
pathological disorders, including colon cancer and inflammatory bowel diseases. In 
spite of this, bacteria also play a part in the promotion of human health. Probiotics and 
prebiotics are known to have a role in prevention or treatment of some diseases (Qin 
et al. 2010). 
 
Gut microbes in particular have been shown to influence physiology and nutrition, and 
have been associated with several chronic diseases such as diabetes (Cani et al. 2007; 
Wen et al. 2008; Larsen & Vogensen 2010; Musso et al. 2010), cardiovascular disease 
(Wang et al. 2011) and obesity (Li & Wang 2008; Turnbaugh et al. 2006; Ley et al. 
2006) but differentiating between correlation and causality proves to be difficult. One 
study investigates a gut microbe by product lipopolysaccharide endotoxin. This 
endotoxin is the only know bacterial product that when subcutaneously infused into 
mice in a pure form, induces obesity and insulin resistance via an inflammation-
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mediated pathway (Fei & Zhao 2013). They isolate an endotoxin-producing bacterium 
isolated from a morbidly obese human‟s gut, and place it in germfree mice resulting in 
induced obesity and insulin resistance in the mice. When the morbidly obese human 
from which the endotoxin-producing Enterobacter was isolated was put on a diet of 
whole grains, traditional Chinese medicinal foods and prebiotics, the relative 
abundance of the endotoxin-producing Enterobacter decreased. During this time the 
volunteer lost a significant amount of body weight, and recovered from hyperglycemia 
and hypertension (Fei & Zhao 2013).  
 
1.7.1 Gut microbial composition 
The microbes present in the gut have been shown to be diverse, with 128 different 
phylotypes being identified in one study (Bik et al. 2006), with many more bacteria  
yet to be described (Guarner & Malagelada 2003). As well as this diversity, different 
types of bacteria have been shown to colonise and inhabit different areas of the gut 
(Figure 1).  Colonisation of gut bacteria begins after birth with environmental factors 
playing an important role, as there are difference in gut composition between infants 
born in developed countries, and those born in developing countries, as well as 
differences between infants born in different hospital wards (Guarner & Malagelada 
2003). Pioneer bacteria are able to modulate gene expression in host epithelial cells 
(Hooper et al. 2001), therefore can create a favourable habitat for themselves, and 
prevent growth of other bacteria that are introduced later. The initial colonisation is 
thus very relevant to the final composition of the flora in adults (Hooper et al. 2002; 
Guarner & Malagelada 2003). The genera Bacteroides, Bifidobacterium, Eubacterium, 
Clostridium, Peptococcus, Peptostreptococcus, and Ruminococcus are predominant in 
human beings (Simon & Gorbach 1986), whereas aerobes (facultative anaerobes) such  
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Figure 1: Human intestinal microflora. Image adapted from Dunne 2001. Showing 
bacterial content and representative species found in the human gut.  
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as Escherichia, Enterobacter, Enterococcus, Klebsiella, Lactobacillus, Proteus, etc 
are among the subdominant genera (Simon & Gorbach 1986; Guarner & Malagelada 
2003).  
 
It has been suggested that gut microbial composition may be associated with colon 
cancer. In a human study, the composition of faecal flora of people with differing risks 
of colon cancer was investigated. High risk of colon cancer was associated with the 
presence of two particular strains of Bacteroides, and low risk appeared to be 
associated with the presence of two particular strains of Lactobacillus and a strain of 
Eubacterium (Moore & Moore 1995). Although the study was not conclusive, it 
suggests that colonic flora may be a major factor that modulates risk of colon cancer 
in humans (Moore & Moore 1995; Qin et al. 2010). 
 
1.7.2 Probiotics and prebiotics 
Bacteria can be implemented to improve human health. A probiotic is a living 
microoorganism that when ingested in specific numbers exerts health benefits beyond 
those of basic nutrition (Guarner & Schaafsma 1998; Gill & Guarner 2004).  
Prebiotics are non-digestible food ingredients that have beneficial effects on the host 
by selectively stimulating growth, activity, or both, of just one or a restricted number 
of bacteria in the colon (Gill & Guarner 2004). Infant formula has been supplemented 
with probiotics in order to prevent diarrhoeal disease in chronically hospitalised 
children. Lactobacillus rhamnosus strain GG has been used as a prophylaxis of 
diarrhoea in undernourished children, especially those who have not been breast fed 
(Guarner & Malagelada 2003).  
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In yoghurt, bacteria used to start the culture improve digestions of lactose and 
eliminate symptoms of lactose intolerance in those who do not efficiently absorb 
lactose (Guarner & Malagelada 2003). 
 
1.8 Folate Synthesis 
Folates are B-class water-soluble vitamins, that are required for cell function and 
development (Bailey & Gregory 1999; Bedhomme et al. 2005). Folate is composed of 
„pteroic acid (Pte) covalently bound to a (poly) glutamate chain‟ (Lu et al, 2007) 
(Figure 2). The pteroic acid (Pte Glu) can then be modified to synthesize a diverse 
family of compounds (Figure 2). Folates are involved in the synthesis of many 
compounds including purines and pyrimidines, methionine and coenzyme A, which 
are all crucial for one-carbon metabolism (Figure 3) (Reed et al. 2006; Lu et al. 2007; 
Balamurugan et al. 2007).  
 
De novo, aromatics compounds are synthesised by the shikimic acid pathway. The 
shikimic acid pathway is responsible for the synthesis of the aromatic amino acids, 
quinones and para-aminobenzoic acid, a pre cursor of folic acid (Figure 4). However 
the shikimic pathway is only found in plants and bacteria. Therefore  animals rely on 
their diet and intestinal microbes for aromatic amino acids and folates as they do not 
possess the required enzymatic activity required for synthesis. 
 
1.9 Folate Metabolism 
Folate metabolism is essential in animals, as it is required for the production of purine 
synthesis, and therefore for DNA and RNA synthesis as well as many other reactions 
including amino acid metabolism and methylation processes (Shane & Stokstad 1975; 
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Figure 2: Chemical structure of folates. Image from Garratt et al. 2005. Folinic acid 
is 5/10 formyl-THF (tetrahydrofolate).  
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Figure 3: The Folate cycle Image adapted from Garratt et al 2005. Abbreviations: 
DHF = dihydrofolate, DHFR = dihydrofolate reductase, DMG = dimethylglycine 
dTMP = Thymidine monophosphate, dUMP = deoxyuridine monophosphate, MS = 
methionine synthase MTHF = methylenetetrahydrofolate reductase SAH = s-
adenosylhomocysteine, SAM = s-adenosylmethionine SHMT = serine 
hydroxymethyltransferase THF = tetrahydrofolic acid, TS = Thymidine synthase 
UMFA = unmodified folic acid. 
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Figure 4: The shikimic acid pathway. Abbreviations: P = phosphate, PABA = para-
aminobenzoic acid, PHB = para-hydroxybenzoic acid, PEP = phosphoenolpyruvate, 
SHK = shikimate,  
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 Shane & Stokstad 1985; Reed et al. 2006; Lu et al. 2007). Folate species can act to 
either accept or donate one carbon units in several reactions collectively known as  
folate mediated one-carbon metabolism (Shane & Stokstad 1985). Tetrahydrofolate 
(THF) is the active form of folate coenzyme that is able to act as the donor or acceptor 
of one-carbon groups for key metabolic reactions, for example 10-formyl-THF is used 
in the biosynthesis of the purine ring (Shane & Stokstad 1985; Bailey & Gregory 
1999). 5-10 methyleneTHF can be reduced to 5-methylTHF by methylene 
tetrahydrofolate reductase (MTHFR). This N-5 methyl group from 5-methylTHF is 
then used in the methionine synthase reaction which results in the synthesis of 
methionine from homocysteine. Methionine is required during protein synthesis, and 
also acts as a methyl donor via its conversion to S-adenosylmethionine (SAM) a 
primary methylating agent involved in over 100 methyltransferase reactions (Shane & 
Stokstad 1985; Bailey & Gregory 1999) (Figure 3).  
 
All folate species have a varying number of glutamate molecules attached. The 
number of glutamates can vary from a single glutamate molecule, through to a chain 
of 9 glutamates attached to the folate species (Lu et al. 2007; Garratt et al. 2005; 
Stover & Field 2011). It is thought that polyglutamated folate species are the most 
common form of intracellular folates, and are the natural substrates for one-carbon 
metabolism enzymes. As substrates for these enzymes, they have shown to be as 
effective, with some more effective than monoglutamates variet ies (Shane & Stokstad 
1985). Polyglutamated species of folate may also be important in the regulation of 
folate mediated one carbon metabolism. There is evidence to show that 
polyglutamates varieties of folates effectively inhibit some of the enzymes required 
for one-carbon metabolism, whilst the monoglutamated forms of the same folate 
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species are weak inhibitors in comparison, suggesting that the glutamate polypeptide 
increases the affinity of the folate to certain enzymes (Shane & Stokstad 1985; Stover 
& Field 2011).  
 
There is evidence to suggest that polyglutamated folates are not transported across the 
cell membrane, or if they are only poorly transported. This results in the metabolism 
of monoglutamated forms of folates to polyglutamated forms of folate within the cell. 
Meaning that cells are able to concentrate folate species to a much higher level than 
available in the external environment, and that the polyglutamates forms are more 
easily retained in the cell (Shane & Stokstad 1985; Stover & Field 2011). 
 
1.10 Folate Deficiency 
The folate cycle is highly complex, meaning that slight perturbations to dietary folate 
may ultimately lead to changes in folate status and risk of disease (Reed et al. 2006). 
Deficiency of folate has been shown to lead to a variety of disorders such as growth 
retardation, asthma, cardiovascular disease, cancer, neural tube defects in pregnant 
women and neurological disorders (McKay 2004; Kim & Yang 2004; Reed et al. 
2006). Due to the substantial amount of evidence with regards to folate deficiency and 
neural tube defects during pregnancy, the folic acid fortification of flour was increased, 
and folic acid supplemented cereal-based products were made mandatory in the US 
and Canada in the late 1990‟s (Kim & Yang 2004). 
 
1.11 C. elegans: a model organism 
The free living nematode C. elegans has long been used as an excellent model 
organism for ageing research. In the wild, C. elegans are often found to proliferate on 
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rotting fruit or compost (Barrière & Félix 2005; Félix & Braendle 2010), however in 
the laboratory environment they can be maintained in petri dishes or in liquid culture, 
and are usually fed on lawns of the E. coli bacterial strain OP50 (Brenner 1974). C. 
elegans has a short generation time; the development from egg to egg laying adult 
takes around 3 days at 25°C. Fully developed adult C. elegans are approximately 1.2 
mm in size, meaning that large numbers of animals can be grown efficiently and 
easily on petri dishes (Byerly et al. 1976).  
 
1.11.1 C. elegans anatomy and lifecycle 
An adult hermaphrodite is compromised of only 959 somatic cells, with the complete 
cell lineage, which is invariant between animals, having been established (Torok-
Storb 1988; Herndon et al. 2002). Worms are enclosed by a cuticle, which is a sturdy 
yet flexible exoskeleton like structure to which the muscles are attached. Food is taken 
in through the mouth, compacted and pumped into the intestine by the pharynx. The 
intestinal lumen of the worm runs through the entirety of the body from the pharynx to 
the anus (Figure 5) (Ward & Thomson 1975; Francis & Waterston 1991).  
 
The lifecycle of C. elegans starts with an embryonic stage, followed by four larval 
stages (named L1-4) followed by adulthood (Byerly et al. 1976). This lifecycle is 
observed in favorable conditions, where food is not limited and the population is not 
at such a high density that overcrowding occurs. If conditions are not favorable, if 
food is scarce, the population is too large or the temperature too high, then the worm 
is able to form a dauer. During dauer formation the larvae complete L1 developmental 
stage, but then go to a predauer stage known as L2d.Worms can remain in dauer state 
for up to 4 months, as they have high fat stores, are non feeding and highly resistant to  
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Figure 5: Anatomy of an adult hermaphrodite  (Image from Worm atlas). A. DIC 
(differential interference contrast) image of an adult hermaphrodite, Scale bar 0.1 mm. 
B. Schematic drawing of anatomical structures, left lateral side.   
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stress. When conditions become favorable, dauers are able to re-enter the lifecycle at 
L4 stage (Figure 6) and progress through to adulthood as normal (Byerly et al. 1976). 
As mentioned, developmental time from egg to gravid egg laying adult takes 3 days at 
25°C. Hermaphrodites finish their reproductive and egg laying cycle around day 6-7 
or adulthood, with a typical total brood size of 300-400 eggs at 25°C. Typical adult 
lifespan of hermaphrodites is approximately 12-14 days at 25°C (Kenyon et al. 1993) 
 
1.11.2 C. elegans as a genetic model organism 
C. elegans have two sexes determined by the presence or absence of a second X 
chromosome. Males have only one copy of the X chromosome (XO), whereas 
hermaphrodites possess two copies (XX) (Brenner 1974). Hermaphrodites can either 
self fertilise or mate with males, but cannot mate with other hermaphrodites. If 
hermaphrodites are left to self fertilise, then males are relatively rare, approximately 1 
in 1000 individuals will be male. However if hermaphrodites mate with a male, then 
progeny will be 50:50 male to hermaphrodites, as half of the progeny will not receive 
a copy of the X chromosome from sperm. Male animals are generally smaller than 
hermaphrodites, but can more readily be distinguished from hermaphrodites by the 
hook on their tail (Brenner 1974).  
 
The self fertilizing trait of hermaphrodites is particularly useful in studies requiring 
isogenic populations, such as genetic screens or lifespan experiments. However, males 
are also useful for outcrossing with other worm strains, for example, to make a wild 
type sibling of an animal with a genetic mutation, or to make a double mutant 
(Brenner 1974). 
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Figure 6: Lifecycle of C. elegans at 22°C. Life cycle from egg through four larval 
stages (L1-L4) to adulthood. 
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The C. elegans genome is predicted to contain 19,000 genes and was fully sequenced 
by the C. elegans sequence consortium which was first published in 1998 and can 
easily be manipulated (Reboul et al. 2001; Kamath & Ahringer 2003). Mutations can 
be induced using a wide range of mutagens – for example X-ray radiation. This makes 
C. elegans the ideal system in which to investigate genes responsible for a particular 
trait. A large number of verified genetic mutants are now readily available from the 
Caenorhabditis Genetics Centre (CGC). Strains of C. elegans can be stored for a 
number of years at -70°C, which is especially useful when working with novel or 
weak strains, as an aliquot of the original strain can be thawed if needed (Brenner 
1974).  
 
1.11.3 C. elegans as a model to study ageing 
The C. elegans genome contains homologs of approximately two thirds of all human 
disease genes, and therefore the worm has become a popular organism for modeling 
human diseases including age-related diseases (Sonnhammer & Durbin 1997; 
Baumeister & Ge 2002). Initially research in the C. elegans aging field was focused 
on the genetics of ageing and single gene mutations that drastically increased lifespan 
of the animal, such as age-1 and daf-2.  
 
An early screen for long- lived mutants (Klass, 1983) revealed at least one long-lived 
strain, which was later found to contain a mutation in the gene age-1. age-1(hx546) is 
a recessive mutant allele in C. elegans that was found to result in a significant and 
robust lifespan increase in both male and hermaphrodite worms (Friedman & Johnson 
2002). age-1(hx546) was found to be associated with a 75% decrease in 
hermaphrodite self- fertility. The study showed that the long- life and reduced-fertility 
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phenotypes cosegregate and are tightly linked to fer-15, a locus on linkage group II. 
age-1(hx546) did not affect the timing of larval molts, the length of embryogenesis, 
food uptake, movement, or behaviour when tested (Friedman & Johnson 2002). At the 
time, the mutant in age-1 was a novel instance of a well-characterized genetic locus of 
which the mutant form results in increased lifespan.  
 
By chance it was discovered that a mutant of the gene daf-2 was also long-lived 
(Kenyon et al., 1993), and that this same mutant had already been shown to cause 
dauer formation at restrictive temperatures (the Daf-c phenotype). Following this 
finding, more Daf-c mutants were tested, but not all showed an extended lifespan.  In 
three different alleles of the daf-2 gene, highly significant effect on lifespan was found. 
Testing of other strains showing the Daf-c identified an allele of daf-23 which 
extended lifespan significantly (Larsen et al 1995), but following further research it 
was discovered that this allele was in the same gene previously described as age-1 
(Malone et al 1996; Morris et al 1996). Due to work on dauer development, it had 
already been shown that the Daf-c phenotype of daf-2 alleles required the presence of 
the daf-16 gene, which has a Daf-d phenotype (Daf-d denotes that the strain is less 
capable of forming dauers as compared to wild type strains) (Riddle et al., 1981). This 
result led to the finding that the longevity phenotype of the daf-2 mutant C. elegans 
also requires daf-16 (Kenyon et al., 1993). Cloning and sequence analysis of the daf-
16 gene revealed daf-16 to be a homolog of human fork-head transcription factors 
FOXO3 and FOXO4 (Ogg et al., 1997). This research led to the discovery that single 
genes in the insulin/IGF-1 signaling (IIS) pathway can have dramatic effects on C. 
elegans lifespan.  
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The discovery that age-1 codes for a phosphoinositide-3-OH kinase (PI3K) (Morris et 
al., 1996) led to the identification of further downstream elements in the IIS pathway. 
Akt/PKB serine/threonine kinases had already been shown to act as downstream 
effectors of PI3 kinases in other model systems (Toker and Cantley, 1997). The newly 
sequenced C. elegans genome was used in attempt to identify homologs in worms. 
The two genes akt-1 and akt-2 were identified and found to have a role in signaling to 
daf-16. The activating mutation mg144 in akt-1 was capable of fully suppressing the 
Daf-c phenotype of age-1 mutant C. elegans. Inhibition of both akt-1 and akt-2 
activity led to complete dauer arrest. This Daf-c phenotype could be completely 
suppressed by a null mutation in daf-16 showing that the two C. elegans Akt.PKB 
homologs AKT-1 and AKT-2 act redundantly to antagonize DAF-16 (Paradis and 
Ruvkun 1998).  
 
There has been much research on the IIS pathway in C. elegans, and there is 
substantial evidence that the IIS pathway is an evolutionarily conserved mechanism of 
longevity from yeast to humans (Barbieri & Bonafè 2003). Similar to daf-2 mutation 
in C. elegans, mutations in the insulin receptor homolog InR in Drosophila 
melanogaster also show a large extension in lifespan (Tatar et al 2001). Foxo, the 
Drosophila homolog of daf-16 has also been implicated in longevity (Giannakou et al 
2004). In mice, inhibition of the IIS pathway has been shown to have protective 
properties against age-onset neurodegeneration- linked proteotoxicity (El‐Ami et al. 
2014). In humans there is evidence to suggest that genetic variation within the 
FOXO3A gene is strongly associated with human longevity (Willcox et al. 2008).   
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More recently, many different approaches are being used in the C. elegans ageing 
field as well as genetic manipulations that influence lifespan, such as environmental 
manipulations for example hormetic treatments, evolutionary studies, population 
studies, models of age-related diseases and drug screening for life extending 
compounds (Olsen et al. 2006).  
 
1.12 The C. elegans/ E. coli model system 
The genetic manipulation of E. coli has great potential as a method of precisely 
manipulating the C. elegans diet to further investigate diet/longevity interactions. It is 
possible to grow C. elegans axenically (with no microbial food source), however this 
has detrimental effects on their growth and development (Lenaerts et al. 2008). There 
have been many studies researching and defining the most suitable axenic media for 
worms in order to provide further information on any effect on lifespan that the 
bacteria might be exerting on the animal. Despite these efforts, worms grown on these 
defined axenic media, do not grow or develop as well as worms reared on live E. coli. 
 
Studies have investigated the effect of maintaining C. elegans on dead E. coli cultures. 
Worms raised on killed bacteria exhibit development problems. Growth arrested E. 
coli used as a food source for C. elegans rescues the effects of axenic culture 
(Lenaerts et al. 2008). With regard to this finding, further work has attempted to 
identify the component of E. coli that is necessary and required for normal C. elegans 
nutrition. Whilst one particular bacterial component which results in normal 
development is yet to be discovered, this research provides compelling evidence that 
for healthy growth and development of C. elegans, there is a nutritional requirement 
that is fulfilled by live, metabolically active microbes (Lenaerts et al. 2008). 
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My research uses the simplified C. elegans / E. coli model to investigate the intricate 
relationship between diet and ageing. In laboratory studies, C. elegans are fed 
monoxenically on E. coli, meaning that the worms are being fed a homogenous and 
genetically well characterized diet. C. elegans are reared and maintained in a 
controlled environment, resulting in negligible environmental change between 
individuals. For lifespan analysis, hermaphrodites are allowed to self fertilise in order 
to produce isogenic populations.  
 
1.12.1 Interactions between E. coli and C. elegans 
It has previously been reported that when C. elegans are maintained on non-
proliferating bacteria, then they show an increased mean lifespan (Garigan et al. 2002; 
Walker & Houthoofd 2005; Saiki et al. 2008). The GD1 E. coli mutant has a deletion 
in the ubiG gene. ubiG codes for a methyl-transferase in the ubiquinone (also called 
coenzyme Q, or Q) biosynthetic pathway, and thus cannot produce coenzyme Q (Saiki 
et al. 2008). Q is found in both eukaryotes and prokaryotes where its main role is 
within the respiratory electron transport chain. Research shows that when C. elegans 
are maintained on GD1 (Q-less) bacteria, they have increased lifespan. Further 
experimentation shows that the lifespan effect is not caused specifically b y the lack of 
Q, but rather because the GD1 bacteria exhibits a defect in respiration (Saiki et al. 
2008). 
 
As mentioned previously, C. elegans maintained on killed bacteria have growth 
defects. In contrast, it has been shown that despite the slow development, worms 
maintained on UV-killed bacteria exhibit an increased lifespan (Gems & Riddle 2000), 
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perhaps as a form of dietary restriction. In concurrence with this finding, another 
study shows that worms kept on non-proliferating bacteria (bacteria that have been 
treated with antibiotics to prevent proliferation), also show an increase in longevity 
(Garigan et al. 2002).  
 
In the lab C. elegans feed on a range of bacteria and yeasts, however little is known 
about their diet in their natural habitat. C. elegans sampled from the wild, regularly 
show signs of bacterial infection, such as bacterial films on the worm cuticle which 
would be considered unusual in lab maintained strains. Freshly isolates worms are 
also found with live bacterial and possibly fungal accumulation in their intestines, 
causing a constipation phenotype (Félix & Braendle 2010).  
 
 1.13 A serendipitous aroD mutant 
Whilst performing lifespan analysis on C. elegans using RNA interference (RNAi) by 
feeding, an E. coli HT115(DE3) RNAi strain was found to increase lifespan of the 
long lived daf-2 mutant by 30-50% (Virk et al. 2012). Further investigation showed 
that the mutant possessed a mutation in the aroD gene, which causes a disruption of 
the shikimic acid metabolic pathway (Figure 4). The shikimic acid pathway is 
responsible for the synthesis of aromatic compounds such as aromatic amino acids,  
quinones and para-aminobenzoic acid, a pre cursor of folic acid. Plasmid 
complementation was then performed to confirm that the increase in lifespan observed 
was due to the mutation in the aroD gene, and was successfully able to rescue the 
lifespan extension observed. An independent aroD mutation was ordered from the 
Keio collection to verify that the lifespan extension seen was not allele or strain 
specific (Virk et al. 2012) 
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The aroD gene codes for the enzyme 3-dehydroquinate dehydratase, an essential 
enzyme in the shikimic acid pathway that is responsible for the production of 
chorismate. In conjunction with this, when shikimic acid was supplemented to the 
media, the lifespan effect caused by the aroD mutant was no longer observed. The 
aroD E. coli is able to grow on peptone media used for lifespan analysis, therefore the 
media must be able to provide the essential aromatic compounds that are required for 
growth, or the appropriate pre cursors of these compounds. To determine whether the 
extended longevity observed was due to any of these compounds being limited in 
availability, compounds that have been shown to support the growth of aro mutants 
were supplemented to the media; these include the aromatic compounds, the folate 
precursor para-aminobenzoic acid (PABA) and the quinine pre cursor para-
hydroxybenzoic acid (PHB). Of these compounds only one, PABA, eliminated the 
extension of lifespan completely.  
 
This finding suggests that a decrease in bacterial folate synthesis in the aroD mutant is 
the major cause of the increased C. elegans lifespan observed. However, when folic 
acid was added to the aroD mutant the long lifespan effect was only partially rescued 
(Virk et al. 2012). As literature suggests that E. coli cannot take up folic acid itself 
(Brown et al. 1974), this evidence seems to suggest that the lifespan effect seen is not 
E. coli specific – i.e. not solely due to a reduction in bacterial folates – and that 
decreased levels of folate in the worm may also have an impact on the extension in 
longevity.  
 
The mechanism behind the increased longevity seen in C. elegans fed on aroD 
remains unclear. The aroD mutant should in theory inhibit folate synthesis; however 
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the E. coli must still be able to synthesize low levels of folate for them to be viable. It 
is possible that there are traces of PABA or  shikimic acid itself present in the media, 
which the mutant E. coli are then able to  synthesize into folate. Measurements of 
folate levels in both the aroD mutant and the wild type E. coli would confirm the 
difference in levels of folate between the mutant and wild type. Measurement of folate 
levels in worms fed on either mutant or wild type E. coli is also required to provide 
knowledge on the effects of folate.  
 
1.14 Aims and Objectives 
I intend to investigate further into the mechanism via which the aroD E. coli mutant 
extends C. elegans lifespan. I aim to determine whether decreasing folate levels is the 
cause behind the increase in animal lifespan. If a decrease in folate levels is the cause 
of the lifespan effect, then I will aim to reproduce the lifespan extension seen with the 
aroD mutant using chemical interventions to decrease folate levels. I will also try to 
delve further into the mechanism via which a decrease in folate levels causes an 
increase in C. elegans lifespan, and endeavor to determine whether the effect is caused 
by a change to the E. coli, a change to the worm or an interaction between the two 
organisms.  
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CHAPTER 2 
MATERIALS AND GENERAL METHODS 
 
2.1 C. elegans strains used 
Strain Genotype/Relevant 
Characteristics 
Source/Origin 
CB1392 nuc-1(e1392) (Lyon et al. 2000) 
N2 Wild type (Brenner 1974) 
SS104 glp-4(bn2) (Beanan & Strome 1992) 
RB1055 gcp-2.1(ok1004) Caenorhabditis Genetics 
Centre (CGC) 
UF208 Wild type This study 
UF209 gcp-2.1(ok1004) This study 
UF215 gcp-2.1(ok1004) 
gqEx37[gcp-2.1,Pgbp-
2::GFP, 
This study 
VC959 tag-330(ok1460) 
V/nT1[qIs51](IV;V) 
(Balamurugan et al. 2007) 
 
UF209 was outcrossed from the RB1055 strain 3 times, UF208 was a wild type  
sibling from the same cross 
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2.2 E. coli strains used 
Strain Genotype/Relevant 
Characteristics 
Source/Origin 
OP50 OP50 ura (Brenner 1974) 
OP50 sulfonamide (Su) 
resistant 
OP50 (R26) This study, (Villarroel & 
Hedges 1983) 
OP50-GFP OP50 (pFPV25.1) (Valdivia & Falkow 
1996) 
aroD mutant HT115(DE3) aroD717::IS1 (Virk et al. 2012) 
Keio collection wild type BW25113 (Baba et al. 2006) 
Keio collection aroD BW25113 aroD (Baba et al. 2006; 
Yamamoto 2009) 
 
2.3 Solutions for C. elegans maintenance 
M9 buffer (7.37g/l Na2HPO4.2H2O (≥99.0%, Sigma-Aldrich), 3.00g/l KH2PO4 
(≥99.0%, Sigma-Aldrich), and 5.00g/l NaCl (≥99.0%, Sigma-Aldrich), to distilled 
water, stirred until dissolved. The solution was then divided into 250ml aliquots and  
autoclaved at 121°C for 20 minutes to sterilise.) 
 
LB (Luria Bertolani broth) (10.0g/l Tryptone (95039, Sigma-Aldrich), 5.0g/l Yeast 
Extract (Y1625, Sigma-Aldrich), 10.0g/l NaCl, to distilled water and mixed 
thoroughly. The solution was then divided into 250ml aliquots and autoclaved to 
sterilise.) 
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2.4 Nematode Growth Media (NGM) Plate Preparation for C. elegans 
maintenance 
These plates were prepared in advance and stored at 4°C until needed. NGM was 
prepared by adding 3.00g/l NaCl, 2.50g/l Peptone (70171, Sigma-Aldrich) or 
Tryptone (dependent on type of plate required) and 20.0g/l Agar (05038, Sigma-
Aldrich) to distilled water and mixed vigorously. The media was then autoclaved at 
121°C for 20 minutes to sterilise. Once the autoclave cycle had completed, the media 
was cooled to 65°C at which point, 1ml/l of Cholesterol (≥99.0%, Sigma-
Aldrich)(cholesterol solution final concentration 5mg/ml dissolved in ethanol), 1ml/l 
of 1M CaCl2 (≥96.0%, Sigma-Aldrich), 1ml/l of 1M MgSO4 (≥99.5%, Sigma-Aldrich) 
and 25ml/l of 1M KH2PO4 (pH 6.0) were added aseptically in a safety flow cabinet. 
The media was then aliquoted into 60 mm plates, ensuring that 15ml was pipetted into 
each plate. 
 
2.4.1 Stock Solutions of compounds to be added to NGM plates 
100x stock solutions of compounds to be added to plates (e.g. folic acid, SMX) were 
prepared, and the appropriate volume added to the cooled agar before the plates were 
poured. SMX and folic acid were dissolved in distilled H2O, with 4M NaOH (≥98.0%, 
Sigma-Aldrich) added to aid dissolving of the compound. folinic acid (96.220, 
Schircks) came in a salt form, and therefore was dissolved in distilled H2O alone. 
para-aminobenzoic acid (PABA) (≥99.0%, Sigma-Aldrich) and para-hydroxybenzoic 
acid (PHB) (≥99.0%, Sigma-Aldrich) are dissolved in >99% ethanol. All compound 
solutions once made were filter sterilised using a 0.2μm filter.  
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2.4.2 Preparation of NGM compound plates 
When compound plates were required (NGM plates plus for example 
sulfamethoxazole (SMX) (S7507, Sigma-Aldrich) or folic acid (16.203, Schircks), the 
media was prepared and autoclaved as above. Once cooled and after the CaCl2, 
MgSO4 and KH2PO4 (pH 6.0) had been added, the appropriate volume of 100x stock  
solution of the compound (section 2.4.1) was added before the media is poured into 
the plates. 
 
2.4.3 Preparation of Minimal Media Plates 
For the aroD mutant bacterial growth assays, minimal media plates were required.  
When preparing the solutions, filter sterilising was performed using a 0.2μm filter, and  
when autoclaved, run on a 20 minute cycle at 121°C. 
 
The following sterile stock solutions were prepared: 
 
Trace Element Solution  
5.00g/l Ethylenediaminetetraacetic acid (EDTA), disodium salt (≥99.0%, Sigma-
Aldrich), 0.50g/l FeCl3(≥97.0%, Sigma-Aldrich), 0.05g/l ZnO (≥99.0%, Sigma-
Aldrich), 0.01g/l CuCl2 (≥99.0%, Sigma-Aldrich), 0.01g/l CoCl2.6H2O (≥99.0%, 
Sigma-Aldrich), 0.01g/l H3BO3 (≥99.0%, Sigma-Aldrich) added to distilled water, pH 
of solution was then adjusted to pH 7.0. The solution was then autoclaved. 
 
10% Glucose (G0350500, Sigma-Aldrich) solution filter sterilised. 
 
20x Phosphates and (NH4)2SO4 solution 
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86.92g/l Na2HPO4 anhydrous (≥99.0%, Sigma-Aldrich), 54.00g/l KH2PO4, 20.00g/l 
(NH4)2SO4 (≥99.0%, Sigma-Aldrich) added to distilled water and then autoclaved. 
 
Amino Acid Solution  
40.0g/l of amino acid mix (see table below) added to distilled water and then 
autoclaved. All amino acids from Sigma-Aldrich 
Adenine 0.8g 
Arginine 0.4g 
Asparagine 1.0g 
Cysteine 0.8g 
Glutamic Acid 1.0g 
Histidine 0.8g 
IsoLeucine 0.6g 
Leucine 1.2g 
Lysine 0.6g 
Methionine 0.8g 
Phenylalanine 0.6g 
Serine 4.0g 
Threonine 2.0g 
Tryptophan 0.8g 
Tyrosine 0.4g 
Uracil 0.8g 
Valine 1.5g 
TOTAL 18.1g 
 
 
10.00 g/l Ca (NO3)2 (≥99.0%, Sigma-Aldrich), filter sterilised. 
 
1% Thiamine (≥99.0%, Sigma-Aldrich), filter sterilised 
 
0.5M MgSO4, filter sterilised 
 
The above sterile stock solutions were combined (20X phosphates and (NH4)2SO4 
solutions (50ml), Amino Acid solution (50ml), 10% Glucose (20ml), Trace element 
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solutions (10ml), 0.5M Mg2SO4 solution (2ml), 10mg/ml Ca(NO3)2 (1ml), 1% 
Thiamine (0.5ml)), and the resulting solution (total volume 133.5ml) was heated in a 
water bath at 65°C and then added to 766.5ml agar solution (20g/l agar) that had been 
autoclaved and cooled. The solution was then aliquoted into 60mm plates, ensuring 
that each plate contained 15ml of media. The poured plates were then left to dry and 
stored at 4°C until needed. 
 
2.5 Preparation of bacterial cultures 
To prepare cultures that were then available to use for seeding plates, 35ml of LB was  
pipetted aseptically into a sterile 50ml polypropylene tube. A disposable inoculating 
loop was then used to inoculate the LB with E. coli from either a frozen stock culture 
or an existing culture if there was no contamination. Once inoculated the tubes were 
then placed into an incubating orbital shaker (Stuart SSL1 Lab-scale orbital shaker) at 
37°C and set to 220rpm and allowed to grow overnight. The liquid cultures were then 
stored at 4°C, until required for seeding plates. 
 
2.6 Measuring bacterial growth on minimal media plates 
Bacterial growth assays were carried out using minimal media plates. If compounds 
were to be added to the minimal media, stock solutions were prepared and added to 
the set minimal media plates, then spread under sterile conditions and allowed to dry. 
Once the plates had dried, bacteria was streaked onto the entire plate using a 
disposable inoculating loop. The plates were then stored at 37°C overnight and 
checked the following day for growth. If the colonies found were small, the plates 
were stored at 37°C overnight for a second time, checked again the following day for 
growth, and images taken. 
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2.7 Seeding plates with E. coli as a food source for C. elegans 
Plates must be seeded 2-3 days prior to usage. Plates were seeded with 100μl of 
bacterial culture (section 2.5) that was placed onto each agar plate using a repeat 
pipette under sterile conditions. The plates were then left on the bench to dry and kept 
at room temperature until use. 
 
2.8 C. elegans strain maintenance 
To ensure that animals were available for lifespan experiments and other research 
when required, populations of all cultures were kept and maintained on NGM plates. 
To keep the populations going, when the animals had starved, sections of the plate 
with starved worms on were cut and placed onto new plates. The cut out section was 
placed onto a seeded plate away from the edge of the bacterial lawn. The starved 
worms then move towards the E. coli food source, and continue development. 
 
2.9 Obtaining a synchronised population of C. elegans by bleaching 
This method was used to obtain eggs from gravid unstarved adult worms that were 
free from the E. coli they were grown on and any contamination. To ensure that 
enough eggs were obtained, generally 8 plates were used for bleaching, with 2 plates 
being kept aside for strain maintenance. In order to ensure that enough worms were 
produced for the egg lay stage, 2 plates per lifespan experiment being performed were 
prepared with eggs from the bleaching protocol. 
 
Each plate was washed with 1-2ml of M9 solution, into a 1.5ml eppendorf tube. The 
M9 from 2 plates was washed into 1 eppendorf tube. The adult worms were allowed to 
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settle on the bottom of the tube, once this had occurred the excess M9 was removed, 
leaving approximately 200μl left in the tube which contained both the worms and M9 
solution. Add 125μl of bleach solution (7:8 sodium hypochlorite (425044, Sigma-
Aldrich) and 4M NaOH respectively) to each tube and the tubes were then shaken 
continually by hand for approximately 3 minutes, monitoring by eye the loss of worm 
definition and cloudiness of solution. Time taken for bleaching process to complete 
depended on lab temperature, age of bleach and number of worms. Once worm 
definition had been lost and the solution had become clear of worm carcasses, the tube 
was immediately filled with M9, and centrifuged for 1.5mins at 3000rpm in a 
Spectrafuge 24D bench top centrifuge (Jencons-PLS). After centrifugation, the 
supernatant was removed, leaving approximately 20-40μl in the tube as to not remove 
the pellet of eggs. To wash the eggs and remove traces of bleach, the tube was then 
refilled with M9 and the pellet dissociated by shaking. The tubes were then 
centrifuged again as before (1.5mins at 3000rpm in a Spectrafuge 24D), the 
supernatant removed, and the tube filled again with M9 for the final wash stage. After 
the third and final centrifugation (1.5 mins at 3000rpm in a Spectrafuge 24D), the 
supernatant was removed as before – leaving 20-40μl in the tube. The numbers of 
eggs obtained were then observed by eye under the microscope. To quantify the 
number of eggs more accurately, the eggs were resuspended in the solution left in the 
tube, and 5μl of this was then placed onto a seeded NGM plate. The number of eggs in 
5μl was then calculated, and eggs placed onto the seeded plates appropriately – 
ensuring that there were 50-200 eggs per plate. 
 
2.11 Obtaining a synchronised population of C. elegans by egg lay 
An egg lay is performed to gain synchronised populations for experiments such as 
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lifespans. The worms produced from the bleaching protocol (section 2.9) cannot be 
used for lifespan experiments as the bleach may have had an adverse effect on them. 
Therefore, the next generation is used for lifespans. To make sure that there were 
enough worms for each lifespan experiment, 4-5 plates per lifespan were used for the 
egg lay. 
 
For the egg lay, 3-5 gravid adult worms were placed onto seeded NGM plates (as  
previously mentioned if the lifespan experiments were comparing mutant to wild type 
these must be seeded with mutant E. coli), and placed at 15°C overnight. The 
following day, the plates were checked to ensure that eggs had been laid, and the 3-5 
adult worms were removed. The eggs were then placed back into the 15°C incubator 
and allowed to develop to late L3 or early L4 stage. 
 
2.11 Measuring the lifespan of C. elegans 
Lifespan experiments were performed using SS104 strain C. elegans. This strain was 
used due its temperature sensitive sterility – at 25°C the adult animals are sterile – this 
made lifespan experiments less complicated as the worms did not need to be 
transferred daily to avoid confusion with progeny. 
 
Sections of plates containing starved worms were cut and placed onto 8-10 seeded 
NGM plates (Figure 8).These plates were then kept in an incubator at 15°C for 4-5 
days until the worms had become gravid, unstarved adults. The animals were then 
bleached to obtain synchronised populations (see section 2.9). Once the eggs had been 
obtained, they were placed onto seeded plates. If the lifespan being carried out was 
comparing the effect on C. elegans lifespan of mutant E. coli and wild type E coli, the 
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plates that the eggs were put on to were seeded (see section 2.7) with the mutant E. 
coli (or OP50 + the highest concentration of SMX if experiment was measuring effect 
of lifespan on OP50 compared to OP50 plus SMX). The plates with the eggs on were  
then placed back into the 15°C incubator for 4-5 days. Once the eggs had hatched and 
the animals had become gravid, an egg lay was performed (see section 2.10). After the 
egg lay, plates with eggs on were kept at 15°C for 3-4 days until the worms had 
developed to late L3 or early L4 developmental stage. At this point, the worms were 
shifted to 25°C to induce sterility and kept overnight at 25°C. The following day, 
when the worms were at L4 stage or young adults, they were picked. Twenty five 
worms were picked onto a seeded plate, with 5 plates per lifespan – a total of 125 
worms per lifespan experiment. The animals were left on these plated for the first 7 
days, after this all worms were transferred on to fresh seeded plates and the scoring of 
the lifespan began. Day 1 of scoring was regarded as the first day of adulthood (young 
adult developmental stage). The worms were scored as Alive, Dead or Censored, and 
scored every alternate day. After the first transfer at 7 days, the worms were again 
transferred onto new seeded NGM plates at day 14. After this transfer there were a 
small number of animals left and therefore no further transfers were required. If plates 
developed mild contamination, the area of agar with the contamination was removed, 
and any worms in the contaminated area scored as censored. If plates developed 
severe contamination, all worms on the plates were scored as censored. 
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Figure 7: Schematic of lifespan protocol, adapted from Marjanne Bourgeois. Lines 
represent C. elegans, black dots represent C. elegans eggs, blue dot containing black 
dots represents C. elegans eggs from bleaching protocol. 
 
Starved worms 
SS104
Chunk onto seeded plate
NGM + Bacteria
15°C
4/5 days
Unstarved, 
gravid worms
EGG PREP 
(bleaching)
NGM + Bacteria          
(if doing mutant vs WT, 
seed with mutant)
15°C
4/5 days
Unstarved, 
gravid worms
EGG LAY   
(3-4 hours or 
Overnight)
Remove adult worms
15°C
3/4 days
Late L3 / early L4 worms
Shift worms 
to 25°C 
overnight
L4 / Young Adult worms
5 plates per lifespan –
25 worms per plate
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2.12 Single Worm PCR 
2.12.1 Preparation of Single worm lysis buffer 
Single worm lysis buffer (50mM KCl (≥99.0%, Sigma-Aldrich), 2.5mM MgCl2  
(≥99.0%, Sigma-Aldrich), 10mM Tris HCl (pH 8.3) (RES3098T-B7, Sigma-Aldrich), 
0.5% NP40 (NP40, Sigma), 0.5% Tween 20 (P1379, Sigma-Aldrich), 0.01% gelatine 
(G7041, Sigma-Aldrich) was prepared and stored at -20°C in 1.5ml aliquots. 
 
10μl/ml Proteinase K (P2308, Sigma-Aldrich) must be added to the lysis buffer, 
before the worms were added.  
 
2.12.2 Single worm lysis 
In order to obtain C. elegans DNA for use in PCR reactions, single worm lysis was 
performed. 5μl of single worm lysis buffer (see section 2.12.1) with added proteinase 
K was placed into each lysis tube. Once the buffer had been added, a single worm was 
picked and added to each tube containing lysis buffer. The tubes were then placed into 
a Thermocycler (Mastercycler 96 well/Thermocycler 5333, Eppendorf) programmed 
to run at 60°C for 60 minutes, and then hold the samples at 95°C for 15 minutes.  
 
2.12.3 PCR reaction used for single worm PCR 
When preparing the PCR reaction, PCR master mix was made – for 16 PCR reactions, 
enough master mix for 20 reactions was prepared (Promega PCR master mix (2x) 
(200μl), Folt-1 (7) primer (8μl), Folt-1 (8) primer (8μl), Folt-1 (9) primer (8μl), 
distilled water (136μl) – Total volume 360μl) 2μl of the DNA from single worm lysis 
was added to each PCR tube, and then 18μl of PCR master mix was added.  
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 The tubes were then place in a Thermocycler (Mastercycler 96 well/Thermocycler 
5333, Eppendorf)  set for the following programme (35 cycles): 
 
Upon completion of the PCR programme, the samples were run on a 1.8% agarose gel 
and visualised using ethidium bromide. 
 
Single worm PCR methodology used was adapted from Plasterk lab protocols 
(Williams et al. 1992). 
The primers used in the PCR reactions were as follows: 
Folt-1 (7): 5‟ - CGA CCA GCT ACT CCA TTC CTC AC - 3‟ 
Folt-1 (8): 5‟ – AGA ACC GAG CCT CTT GAA AC – 3‟ 
Folt-1 (9): 5‟ – GCA AGA GCC CAC CAC AAT GAC C – 3‟ 
Primers were designed using ApE - A Plasmid Editor Version 1.17 (M. Wayne Davis 
2009). 
 
Figure 8: Positions of folt-1 primers used for genotyping 
 
Folt-1 PCR was performed with 3 primers (folt-1 (7),(8) and (9)). The expected PCR 
products were: 
In folt-1 mutants that possessed the folt-1 deletion: X+Y = 646 bp 
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In folt-1 wild type animals that did not possess the folt-1 deletion: Z = 809bp 
This allowed us to genotype worms as homozygous mutant, homozygous wild type or  
heterozygous, as the bands were different enough in size that they would be resolved 
when products were run on a gel.  
 
2.12.4 Agarose gel electrophoresis 
10 µl of each sample was run on a 1% agarose (MB1200, Melford) gel and visualised 
with ethidium bromide. Gels were run for approximately 30 minutes at 110V.  
 
2.13 Detection and quantitative determination of in vivo folate by 
mass spectrometry 
2.13.1 Solutions for in vivo folate extraction 
Extraction buffer used was a 50:50 mix of aqueous Buffer (80:20 methanol: distilled 
water, 0.1% ascorbic acid (≥99.0%, Sigma-Aldrich), 20mM ammonium acetate 
(≥98.0%, Sigma-Aldrich)) and methanol. Extraction buffer was also spiked with 
methotrexate that had 6 glutamates (16.416, Schircks) (2 µl in 1000 µl), as 
methotrexate with 6 glutamates does not occur in nature, and therefore allowed us to 
ensure that the extraction protocol was efficient. This buffer was made fresh daily, and 
stored on ice before use. Methotrexate with 6 glutamates, 5-formyl tetrahydrofolate 
with 3 glutamates (16.283, Schircks), and folinic acid were used as standards at a 
concentration of 1mg/ml. 
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2.13.2 Folate extraction protocol for E. coli samples 
8-10 plates were seeded with 100 µl of bacterial culture and left at room temperature 
for 2 days. After this the plates were moved to 25°C for 1 day, so as to emulate the 
conditions used during a lifespan experiment.  
 
For extraction, approximately 1.5ml of M9 was placed on to each plate, and the E. coli 
lawn scraped with a glass spreader under sterile conditions. The M9 containing the E. 
coli from each of the plates, was then taken off and pooled into a 15ml polypropylene 
tube. The volume of contents in each tube was then measured, and the optical density 
at 600nm (OD600) measured. Samples were diluted 1 in 5 (200μl of sample added to 
800μl of M9) for OD measurement. The 15ml tubes were then placed in a centrifuge 
(Sanyo Harrier 18/80 refrigerated) and spun at 4000rpm for 5 minutes. The samples 
were then removed from the centrifuge and the supernatant poured away. The 
bacterial pellet in each tube was left to dry for 2 minutes, after which the tubes were 
placed in liquid nitrogen to snap freeze the bacterial pellet.  
 
To calculate the volume of extraction buffer (see section 2.13.1) to be added to each 
sample, the volume of contents in each tube was multiplied by the OD600. This value 
was then multiplied by 37.5 (an arbitrary value calculated from preliminary work) to 
obtain the volume of buffer to be added in μl. Using this method  the volume of buffer 
per bacteria would be constant over all samples. After 10 minutes the tubes were 
removed from the liquid nitrogen and the calculated volume of extraction buffer, 
added to each tube. As the pellet was frozen, vigorous mixing was required to mix the 
bacterial pellet with the extraction buffer. Once mixed thoroughly, each sample was 
then transferred into a sterile eppendorf tube, and then sonicated in an ice bath for 10 
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seconds, 3 times with a pause of 20 seconds in between each sonication to prevent the 
probe from heating. 
 
The samples were then centrifuged (eppendorf centrifuge 5415 R) further at 4°C for 5 
minutes at 13000rpm. The supernatant was transferred to a sterile eppendorf, as the 
supernatant contained the folates that have been extracted. At this stage the samples 
were either stored at -80°C, and centrifuged again before they were to be run; or if 
they were to be analysed on the same day as preparation, spun in the eppendorf 
centrifuge 5415 R at 13000rpm for 5 minutes at 4°C. After this final centrifugation, 
the supernatant was again transferred to a sterile eppendorf tube and taken for analysis.  
 
2.13.3 Folate extraction protocol for C. elegans samples 
The extraction protocol used for worm folates was similar to the bacterial extraction,  
however there were a few adaptations. One such change was that the samples were 
snap frozen with quick thawing twice to break open the worm cuticle, not once as in 
the bacterial samples. Also instead of adding extraction buffer to the pellet after snap 
freezing, methanol spiked with methotrexate 6 glutamates was added. Instead of 
sonication, glass beads were added to each sample. The samples were covered in foil 
and securely placed on to an orbital shaker set to 125rpm (Stuart SSL1 Lab-scale 
orbital shaker) at 37°C for 1 hour.  
 
2.13.4 Analysis of folate levels in E. coli and C. elegans extraction samples 
The protocol for folate extraction and running of samples was obtained by adapting 
procedures from Garratt et al (2005) and Lu et al (2007). Samples were run using a 
C18 reversed phase column (Waters Acquity BEH, 100 mm x 2.1 mm) reverse phase 
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high pressure liquid chromatography (HPLC) with dimethylhexylamine (98%, Sigma-
Aldrich) as an ion pairing agent. The mobile phase consisted of methanol with 5mM 
dimethylhexylamine, at a flow rate of 0.2mL/min. The injection volume was 10 µl. 
The mass analysis was run by negative electrospray ionisation time-of-flight (negative 
ESI TOF) utilising a quadrupole time-of- flight (Q-TOF) Premier instrument (Waters 
Corporation) calibrated with sodium formate and with dynamic correction from a 
leucine encephalin lock spray. Sampling cone voltage was -35V and capillary voltage 
was -2500V. The peaks obtained by selecting the specific mass were integrated using 
MassLynx software (Waters Corporation) and used as an indication of quantity. The 
peaks generated by known metabolites were also integrated and the peak 
corresponding to coenzyme A was chosen for use in normalization because it was 
large and there was little variation between samples.  
 
2.14 C. elegans fecundity assay 
All fecundity assays were performed using N2 strain C. elegans at 25°C so as to 
emulate the conditions experienced during lifespan experiments. Populations of N2 
worms were synchronised by bleaching (see section 2.9) and the eggs obtained 
pipetted onto NGM plates supplemented with 128µg/ml SMX. Once hatched, the 
larvae were allowed to develop to gravid adults and then an overnight egg lay (see 
section 2.10) on 128µg/ml SMX plates was carried out. After the egg lay, plates were 
kept for 3 days or until the worms had developed to early L4 developmental stage. 
Individual L4 worms (n=20)  were picked onto 20 separate plates per condition. In 
this case there were 3 conditions: control (no supplementation), 16 µg/ml SMX and 
128 µg/ml SMX, and this was counted as day 0 of adulthood. Once worms had begun 
laying eggs they were transferred to freshly seeded plates daily. The previous plates 
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were kept at 25°C for 1-2 days to allow the larvae to develop and then the number of 
viable progeny was counted. Dead eggs were not included in counts of progeny, and 
counts of progeny of worms that then crawled off of the plate were not included in 
final analysis. 
 
2.15 C. elegans motility assay 
Motility assays were performed using SS104 strain worms. Bleaching (section 2.9) 
and an egg lay (section 2.10) were carried out as described above with worms being 
grown and developing on plates supplemented with 128 µg/ml SMX and maintained 
at 15°C. Once progeny from the egg lay had developed to L3/early L4 stage the plates 
were moved to 25°C to induce the temperature sensitive sterility associated with the 
SS104 strain. The next day, worms that were at L4 stage were picked - 10 worms per 
plate were put onto 16 plates per condition (n=160 per condition).  In this case there 
were 3 conditions: control (no supplementation), 16 µg/ml SMX and 128 µg/ml SMX, 
and this was counted as day 0 of adulthood. Motility was scored from day 1 every 
alternate day until all worms were dead. Motility was scored as one of 3 classes A, B, 
C or dead (Herndon et al. 2002)  
 
2.16 Transformation of plasmid R26 from E. coli C600 into E. coli  
OP50 
(Method from John Ward, UCL, April 2011) 
Two sets of plates were prepared; NGM plates as above and minimal M9 plates. 
Minimal M9 plates were prepared by adding 6.00 g/l Na2HPO4, 3.00 g/l KH2PO4 and 
5.00 g/l NaCl and 20.0 g/l agar, then autoclaving for 20 minutes at 121ºC. Once the 
media had been autoclaved, 10 ml/l of 2M NH4Cl (≥99.0%, Sigma-Aldrich), a final 
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concentration of 4μg/ml of Uracil (≥99.0%, Sigma-Aldrich), 1ml/l of MgSO4, 1ml/l of 
CaCl2, a final concentration of 0.4% Glucose and 32μg/ml  SMX were added to the 
media before the plates were poured. This concentration of SMX was used as it is 
selective against OP50. The two E. coli strains were grown separately in LB for OP50 
and LB with 50 μg/ml ampicillin for C600 R26.  Then 50μl of overnight culture of 
each strain was taken, and pipetted onto the same spot of a NGM plate (both strains 
are now mixed). Using a sterile spreader, the cells were spread out onto the NGM 
plate, and grown overnight at 37ºC. The next day a swath of growth was removed 
from the NGM plate and streaked out onto a minimal M9 plate containing SMX to 
obtain single colonies. This plate was then incubated at 37 ºC for 48 hours to allow 
single discrete colonies to grow. Minimal M9 plates were prepared as above, however 
in place of SMX, a final concentration of 50 μg/ml ampicillin (A1593, Sigma-Aldrich) 
was added. Onto these plates single individual colonies from the minimal M9 plate 
containing SMX were streaked out, one colony per plate. If the colonies from the M9 
SMX plates grew on the M9 ampicillin plates then R26 plasmid had been successfully 
transferred. Permanent stock cultures of this E. coli OP50 R26 strain were then made 
and the strain was also frozen for future use.  
 
2.17 Measuring the GFP Intensity of OP50-GFP 
E. coli were seeded (see section 2.7) onto plates with the appropriate supplementation 
and left at room temperature for 2 days. After this time, the plates were placed at 25°C 
overnight. Images of the middle of the lawn were taken using a Leica M165 FL 
stereomicroscope with a GFP2 filter. Images were analyzed in ImageJ. Files were 
opened, and equivalent areas of each image measured for intensity.  
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2.18 Measuring the OP50-GFP accumulation within the intestinal 
lumen of C. elegans 
Worms were prepared for and set up for lifespan analysis as described (see section 
2.11); using GFP OP50 to seed plates (see section 2.7). All worms were checked daily 
for E. coli accumulation from day 1 of adulthood using a Leica M165 FL 
stereomicroscope with a GFP2 filter that has a 510 nm + long pass emission spectrum 
that allows GFP to be distinguished from autofluorescence. Once animals begun to 
accumulate E. coli, they were scored for both survival and accumulation every 2 days. 
Individual worms were scored as having no accumulation, partial accumulation or full 
accumulation. For this study only accumulation in the lumen of the worm was 
included, with bright spots in the pharynx area or elsewhere discounted.  
 
2.19 Production of the gcp-2.1 genomic transgene 
To make the gcp-2.1 genomic transgene, a genomic fragment containing the predicted 
gcp-2.1 gene was amplified using the primers  
R57gen_5: 5‟CTTAGGTTGGATCTCGTTGCTTGC 3‟ and  
R57gen_3: 5‟ TGTGTGGAAAGTGTGGTGAAGC 3‟ 
using N2 genomic DNA as a template. 10 ng/μl of the PCR fragment with 90 ng/μl of 
marker plasmid gpb-2::GFP (Van der Linden 2001) was injected into UF209 gcp-
2.1(ok1004) worms using a Leica DMI6000B microscope and Eppendorf FemtoJet 
and InjectMan Ni2 microinjection unit.  A line transmitting the transgene mosaically, 
as assessed by GFP, was isolated (UF215).  
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2.20 Statistical Analysis 
Analysis of lifespan data was performed using statistical software JMP Version 8.0.2 
(SAS Institute Inc 2009). JMP analyzes lifespan data by calculating estimates of 
survival functions using the product-limit Kaplan-Meier model for one or more groups 
of right-censored data. Statistical significance is then determined using Log-Rank and 
Wilcoxon tests of fitting to the Kaplan-Meier model. 
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CHAPTER 3 
BOTH aroD AND a TARGETTED CHEMICAL INTERVENTION 
INCREASE LIFESPAN IN C. ELEGANS 
 
3.1 Introduction 
The aroD mutant E. coli provides us with a novel potential life extending pathway to 
investigate. With its substantial increase in animal longevity, it is clear that it has 
benefits for the animal. The exact pathway or mechanism behind this extended 
lifespan is not clear. Further investigation is needed to determine whether this increase 
in longevity is associated with any negative side effects such as reduced fertility. 
Uncovering the mechanism via which the aroD mutant is working is essential, as 
mutating gut bacteria is not a viable option for the human population.  
 
As described in chapter 1 (section 1.13), data suggests that aroD may be causing its 
effect via a folate dependent pathway, rather than other aromatics. The no vel aroD 
mutant was found in a HT115(DE3) strain of E. coli, commonly used for RNAi 
(Timmons et al. 2001). In order to investigate the role of the folate pathway with 
regards to ageing in other strains of E. coli, including the E. coli strain most 
commonly used in C. elegans research, we may be able to use a drug to mimic the 
effect of the aroD mutant E. coli it is having. If successful, this drug has the potential 
to be taken as a supplement, a more feasible intervention for humans. The 
sulfonamides, also known as anti- folate drugs would be the ideal class of drug to 
investigate for such a drug. 
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3.1.1 Sulfa drugs 
Sulfa drugs, which are also known as sulfonamides, represent some of the world‟s 
most widely used antibiotics, and are known to inhibit folate synthesis (Connor 1998; 
Castelli 2001). They are structurally analogous to para-aminobenzoic acid (PABA), in 
that sulfonamides have the substitution of the carboxyl group in PABA with a sulfa 
derivative. (Castelli 2001). During folate synthesis, PABA and dihydropteroate 
pyrophosphate condense to form dihydropteroate with the aid of the enzyme 
dihydropteroate synthase (DHPS). The dihydropteroate is then used as a substrate to 
form dihydrofolate (DHF) and ultimately tetrahydrofolate (THF) (Castelli 2001). 
Sulfonamides compete with PABA for DHPS, with some sulfonamides reported to be 
alternative substrates for the DHPS enzyme, which can convert sulfonamides to sulfa-
derivative. Due to this competition, sulfonamides inhibit folate synthesis, resulting in 
folate depletion (Roland et al. 1979; Castelli 2001).  Animals and humans cannot 
synthesis folates, as they lack the required enzymes. Due to the lack of DHPS in 
particular, sulfonamides can be used effectively in humans.  
 
In 1932 it was reported that a red dye 4'-sulfamyl-2,4-diaminoazobenzene, more 
commonly known as prontosil, showed a consistent curative action for streptococcal 
infection in many experiments (Domagk 1957; Stokstad & Jukes 1987). Shortly after 
this it was announced that prontosil and other sulfonamide related compounds also 
proved effective against pneumococcal and staphylococcal infections (Domagk 1957). 
In 1935 these findings were published, making prontosil the first sulfonamide to be 
accepted as having a practical value with regards to treating infectious disease 
(Domagk 1957). The publication of these data led to intensive research in this field in 
several countries. With the interest in sulfonamides growing, treatments for many 
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diseases such as gonorrhea and meningitis epidemica became available and were very 
successful – after a few years of sulfonamide treatment the number of children‟s lives 
saved was approximately 10,000 in England alone. (Domagk 1957).  Sulfonamides 
enabled the causal treatment of many diseases for the first time, especially when 
combined with other antibiotics, which were introduced later, such as penicillin. More 
recently sulfonamides were investigated for being used to treat malaria, as they inhibit 
malaria parasites (Ferone 1977), and are currently being looked into for treatment of 
HIV due to their anti-viral properties (Scozzafava et al. 2003). One sulfonamide in 
particular, indisulam (E7070), is in advanced clinical trials in Europe and the USA as 
a new anti-cancer agent, it treats solid tumors via a multifactorial mode of action. 
Indisulam has been found to strongly inhibits carbonic anhydrase, a critical enzyme 
shown to be associated with cancer involved in many physiological processes, and 
significantly alters gene expression levels of several transcripts (Supuran 2003).  
 
There are many different sulfonamide drugs, and in the 1970‟s and 1980‟s in 
particular, different sulfonamides were used widely to treat different diseases such as  
urinary tract infections (UTI‟s), acute respiratory tract infections, and Crohn‟s disease 
(Björkman & Phillips-Howard 1991). However, as successful as these drugs were, 
they were not without reported side effects. Side effects reported ranged from mild to 
fatal, and several organs and tissues were reported to have been effected, with 
reactions related to blood, skin or liver being reported for all sulphonamides 
(Björkman & Phillips-Howard 1991), it is worth mentioning however that doses of 
drugs used when these side effects were observed were high (Björkman & Phillips-
Howard 1991). 
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 In this research sulfamethoxazole (SMX) was used, as it is still used clinically to treat 
urinary tract infections in combination with trimethoprim, Trimethoprim makes the 
bacteria more susceptible to SMX (Dodd 2004). The SMX-trimethoprim combination 
is administered at a much lower dose 480 mg single strength (80 mg trimethoprim: 
400 mg SMX), or 960 mg double strength (160 mg trimethoprim: 800 mg SMX) per 
day administered three times a week, compared to the Björkman study mentioned 
above, where the dose of SMX used was 1600mg (Fischi et al. 1988; Ruskin & 
LaRiviere 1991; Leoung et al. 2001).  
 
3.1.2 Preliminary study on SMX for use in this study 
Preliminary work performed by a volunteer in the lab Andrea Bender and David 
Weinkove in our lab set out to determine concentrations of SMX supplementation that 
could be used in nematode growth media (NGM) plates, that would still allow the 
growth of the OP50 E. coli used. A range of concentrations were tested from 8 to 512 
µg/ml final concentration SMX to determine the concentration that would prevent E. 
coli growth. At all of these concentrations there was a visible E. coli lawn, therefore 
these doses of supplementation were able to treat the E. coli and still allow growth. 
After these initial tests, lifespan analysis was performed using SMX supplementation, 
with data showing that worms maintained on SMX-treated E. coli having extended 
lifespan. However, Andrea did not have previous experience of working with C. 
elegans, and had not performed lifespan analysis before. In addition to this, the 
numbers of animals in these lifespans were small so we could not be confident in the 
results obtained. 
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3.1.3 Aims and Objectives 
The novel aroD mutant E. coli had been shown to cause a significant increase in C. 
elegans lifespan. The aroD gene is involved in the early stages of the shikimic acid 
pathway, meaning it is upstream of the resulting folates produced, and thus there are 
several steps before the final folate product in which the mutant could be causing the 
lifespan extension. In this chapter, firstly I aim to test whether animals fed on the 
aroD mutant E. coli are indeed long lived in the lab conditions in Durham. Secondly, I 
aim to use SMX as a targeted pharmalogical intervention to mimic the effect of the 
novel aroD mutant on worm lifespan in OP50 E. coli widely used in C. elegans 
research, and determine whether the lifespan extension observed is indeed folate 
specific 
 
3.2 Results 
3.2.1 Replicating the aroD lifespan effect 
Lifespan analysis was performed using the novel aroD mutant on both tryptone and 
peptone based media. Tryptone is a casein peptone used as it was not animal based, 
like peptone (Man 1960; Pham et al. 2005). Both types of media were used in order to 
determine whether the aroD mutant E. coli increased C. elegans lifespan more 
strongly on one type of media over the other. Data show that worms maintained on the 
aroD mutant living on average 25% longer than control on peptone media (P<0.0001)  
(Figure 9a), and 15% longer on tryptone media (P=0.0006) (Figure 9b). In the same 
experiment, the lifespan of worms maintained on aroD E. coli with 500 µM 
exogenous folic acid supplementation added to the plates was analysed. Data show 
that the lifespan was partially rescued with folic acid supplementation, but not  
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Figure 9:  aroD E. coli extends lifespan in C. elegans. A) Lifespan analysis 
performed using rich agar and peptone media. C. elegans strain SS104, Control = 
HT115(DE3) wild type E. coli, aroD = HT115(DE3) aroD mutant E. coli. Folate 
concentration used  = 500 µM. Control n = 119 mean lifespan = 11.24 days, aroD n = 
72 mean lifespan 14.01 days (P<0.0001), aroD + Folate n = 45 mean lifespan 12.36 
days (P=0.0246). B) Lifespan analysis performed using rich agar and tryptone media. 
C. elegans strain SS104, Control = HT115(DE3) wild type E. coli, aroD = 
HT115(DE3) aroD mutant E. coli Control n = 124 mean lifespan 12.94 days, aroD n 
= 97 mean lifespan = 14.85 days (P=0.0006). Data shown are representative of 2 
biological replicates. 
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completely (Figure 9a), confirming previous findings. Whilst the aroD mutant did 
significantly increase lifespan in these lifespan analyses, the observed increase in 
lifespan was smaller than observed in previous studies in London and Durham, where 
the increase in lifespan caused by aroD was consistently between 30-50%. This 
suggests that either, the aroD mutant had lost the ability to increase animal lifespan – 
perhaps another mutation had occurred, or, the effect caused by the aroD mutant is 
sensitive to slight alterations in media, and there had been a change in the media. 
 
3.2.2 Using growth assays to confirm the status of the aroD mutant 
To validate the status of the aroD mutant by testing for auxotrophy for aromatic 
compounds, growth assays were performed on minimal media containing trace 
elements, aromatic amino acids and glucose. On this specific minimal medium (see 
section 2.4.3), the levels of folate present were not sufficient for the folate sensitive 
aroD mutant to grow. On this growth selective media, supplementation with 40 µg/ml 
(approximately equal to 250 µM) para-aminbenzoic acid (PABA) was able to rescue 
growth of the aroD mutant (Figure 10). This result is expected as E. coli are able to 
take up and utilise PABA in the media (Huang & Pittard 1967; Carter et al. 2007). 
Growth assays on minimal media showed that para-hydroxybenzoic acid (PHB) a 
precursor of quinones was able to rescue growth of the aroD mutant E. coli (Figure 
11). This result was unexpected, as it suggested that the lifespan effect caused by 
aroD may be due to a lack of quinones similar to the GD1 E. coli (Saiki et al. 2008). 
Lifespan analysis showed that PHB did not rescue the aroD induced increase in C. 
elegans lifespan, and therefore the lifespan effect was not quinone specific (Figure 12) 
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Figure 10: PABA rescues growth of aroD mutant on minimal media. PABA 
supplementation = 40µg/ml final concentration. Panels A-C show growth of wild type 
E. coli with no supplementation, ethanol supplementation and PABA supplementation 
respectively. Panels D-F show growth of the aroD mutant with no supplementation, 
ethanol supplementation and PABA supplementation respectively. All conditions 
were performed in triplicate with one representative plate shown.  
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Figure 11: Both PHB and glycine rescue growth of aroD mutant on minimal 
media. PHB supplementation = 40µg/ml final concentration. Panels A-C show growth 
of wild type E. coli with no supplementation, glycine supplementation and PHB 
supplementation respectively. Panels D-F show growth of the aroD mutant with no 
supplementation, glycine supplementation and PHB supplementation respectively. All 
conditions were performed in triplicate with one representative plate shown. 
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Figure 12: PHB does not rescue the increased lifespan observed in C. elegans 
maintained on aroD E. coli. Lifespan analysis performed on peptone high purity agar.  
C. elegans strain SS104, wild type = HT115(DE3) E. coli, aroD = HT115(DE3) aroD 
mutant E. coli. PHB was supplemented at the concentrations stated. Wild type n = 406 
mean lifespan = 14.70 days, Wild type + 25 µM PHB n = 121 mean lifespan = 14.06 
days (n.s), Wild type + 250 µM PHB n = 130 mean lifespan = 14.60 days (n.s), aroD 
n = 386 mean lifespan = 20.73 days (P<0.0001), aroD + 25 µM PHB n = 253 mean 
lifespan = 21.63 days (P<0.0001), aroD + 250 µM PHB n = 219 mean lifespan = 
21.46 days (P<0.0001). Representative data is shown from 2 biological replicates.  
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Minimal media was used to determine whether folate supplementation would rescue 
the growth of the mutant E. coli, as it had been able to rescue the lifespan increase of 
worms maintained on the mutant E. coli. Minimal media was supplemented with the 
same high concentration of exogenous folic acid as used in lifespan analysis, 500 µM 
folic acid, and a lower concentration of 250 µM folic acid. Folate supplementation 
was able to rescue the growth of the E. coli (Figure 13), which was surprising as 
literature shows that E. coli, and other bacteria that make their own folate typically  
cannot take up exogenous folate (Shane & Stokstad 1975; Bedhomme et al. 2005).  
 
3.2.3 Folic acid can breakdown into para-aminobenzoyl-glutamate ( PAB-glu) 
Further research into the literature shows that chemically synthesised folic acid can 
contain trace amounts of PAB-glu a breakdown product. PAB-glu can be taken up by 
bacteria and fed into the folate cycle (Carter et al. 2007). This could explain why 
folate was rescuing the growth of E. coli, and perhaps the partial rescue in lifespan 
effect seen with folic acid supplementation as well. As a result of this finding, we 
looked into alternate more specialised manufacturers of synthetics folates. We found a 
supplier, Schircks laboratories, which specialised in folate production.  
 
3.2.4 Lifespan analysis with aroD on high purity agar  
The growth assays show that the aroD mutant did not grow on the minimal media 
without para-aminobenzoic acid (PABA) supplementation. This suggests that the 
mutant has not changed or reverted, but I did not check the mutant by PCR or 
sequencing. Perhaps subtle changes in the media used for lifespan analysis was the 
reason that the mutant was causing a 15-25% increase in lifespan, rather than the 
expected 30-50% increase. The dilution of the aroD effect on lifespan correlated to a  
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Figure 13: High concentrations of exogenous folate rescue growth of the aroD 
mutant on minimal media. Panels A-D show growth of wild type E. coli with no 
supplementation, 250 µM folic acid supplementation, 500 µM folic acid 
supplementation and PABA supplementation respectively. Panels E-H show growth of 
the aroD mutant with no supplementation, 250 µM folic acid supplementation, 500 
µM folic acid supplementation and PABA supplementation respectively. PABA 
supplementation = 40 µg/ml final concentration. All conditions were performed in 
triplicate with one representative plate shown.  
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change in the batch of agar used in the lab. To address this question we ordered high 
purity agar, purified agar used in vitamin assays (05038, Sigma-Aldrich), and 
performed lifespan analysis with our novel mutant and an independent aroD mutant 
obtained from the Keio collection (Baba et al. 2006). The data show that on high 
purity media, our novel mutant significantly increased mean worm lifespan by 65% 
(P<0.0001), and the independent aroD mutant increased the mean lifespan of worms 
by 35%, also significant (P<0.0001) (Figure 14). These data confirm that the aroD 
mutant is media sensitive. Perhaps the medium used in previous lifespan analysis 
contained PAB-glu or a source PABA, which resulted in the E. coli using PABA to 
restore inhibited folate synthesis. If folate synthesis was restored, then it would be 
expected that an increase in lifespan would not be observed. Due to this finding, high 
purity agar was used for all further lifespan experimentation performed using the aroD 
mutant E. coli, in attempt to minimize sources of PABA available from the media. 
 
3.2.5 The effect of PABA and folate supplementation on aroD  
In light of the finding that synthetic folate can contain traces of PAB-glu which can 
then be used by E. coli to synthesise folates, we decided to perform lifespan analysis 
with lower amounts of folate supplementation, in attempt to reduce the availability of 
PAB-glu to the E. coli. Survival assays were performed with 250 µM, 100 µM, 25 µM 
and 10 µM folic acid, and also 100 µM and 10 µM folinic acid supplementation. Data 
show that 10 µM, 25µM and 100µM folic acid partially rescued the lifespan extension 
caused by the mutant E. coli, whereas the lifespan curve for 250 µM folic acid 
supplementation completely rescued the lifespan effect seen (Figure 15a). Both 
concentrations of folinic acid partially rescued the lifespan effect seen, showing a 
similar level of rescue to that of 10 µM and 25 µM folic acid (Figure 15b).  
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Figure 14:  An independent aroD mutant from the Keio collection extends 
lifespan in C. elegans. Lifespan analysis performed using high purity agar and 
peptone media. C. elegans strain used SS104, Wild type = HT115(DE3) E. coli, aroD 
= HT115(DE3) aroD mutant E. coli. Keio represents equivalent strains from the Keio 
collection. Wild type n = 126 mean lifespan = 12.42 days, Keio wild type n = 131 
mean lifespan = 12.45 days (n.s), aroD n = 127 mean lifespan 20.60 days (P<0.0001), 
Keio aroD n = 128 mean lifespan 16.76 days (P<0.0001).  Representative data shown 
from 2 biological replicates. 
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Figure 15:  Exogenous folate partially rescues the increased lifespan of C. elegans  
maintained on aroD mutant E. coli. Lifespan analysis performed using high purity 
agar and peptone media with folic and folinic acid supplementation at the 
concentrations stated. C. elegans strain used SS104. Control = HT115(DE3)  E. coli,  
aroD = HT115(DE3) aroD mutant E. coli. A) Folic acid supplementation: Control n = 
233 mean lifespan = 15.06 days, aroD n = 225 mean lifespan = 20.51 days (P<0.0001), 
aroD + 10 µM folic acid n = 132 mean lifespan = 18.06 days (P<0.0001), aroD + 25 
µM folic acid n = 127 mean lifespan = 18.46 days(P<0.0001), aroD + 100 µM folic 
acid n = 120 mean lifespan = 17.72 days (P<0.0001),, aroD + 250 µM folic acid n = 
129 mean lifespan = 15.96 days (n.s). B) Folinic acid supplementation: Control and 
aroD same as used in A), aroD + 10 µM folinic acid n = 124 mean lifespan = 19.64 
days (P<0.0001), aroD + 100 µM folinic acid n = 134 mean lifespan = 18.99 days 
(P<0.0001).  
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Lifespan analysis were also performed with PABA supplementation at 25µM and 
250µM to determine whether lower levels of PABA would rescue the aroD lifespan 
effect. Data shows that both 25 µM and 250 µM completely rescue the increase in 
lifespan, without being toxic to the animals (Figure 16). Together these data show that 
the lifespan increase observed when C. elegans are maintained on aroD mutant E. coli 
is folate specific. 
 
3.2.6 A drug can be used to target folate synthesis and increase C. elegans 
lifespan 
The aroD gene is involved in the production of chorismate in the early stages of the 
shikimic acid pathway. As data suggest that the lifespan effect caused by aroD mutant 
E. coli is specific to folate synthesis, it raised the question, whether this folate specific 
lifespan increase was unique to aroD E. coli strain, or could it be applied to other 
bacterial strains. I also aimed to find an intervention to folate synthesis that showed a 
more robust response with regards to the media used. I used sulfamethoxazole (SMX) 
as a chemical intervention to inhibit folate synthesis in the E. coli strain OP50, the 
strain of bacteria typically fed to C. elegans in the lab. Following the preliminary 
research performed by Andrea Bender, for the purpose of this research three 
concentrations of SMX were chosen for use. These were 16 µg/ml, 64 µg/ml and 128 
µg/ml SMX as these represented a low, medium and high dose based on the previous 
study. Survival assays using these 3 concentrations of SMX to treat the OP50 E. coli 
were performed on the same standard, not high purity agar that had been used for the 
initial aroD lifespans. On tryptone based media, results show that all concentrations of 
SMX used increase C. elegans lifespan significantly. Supplementation with 128 µg/ml 
SMX showed the largest increase in lifespan of 26% (P<0.0001), with 64 µg/ml SMX  
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Figure 16: A high concentration of PABA supplementation completely rescues 
the increased lifespan of C. elegans maintained on aroD mutant E. coli. Lifespan 
analysis performed using high purity agar and peptone media with PABA 
supplementation at the concentrations stated. C. elegans strain used SS104. Control = 
HT115(DE3)  E. coli,  aroD = HT115(DE3) aroD mutant E. coli. Control n = 233 
mean lifespan = 15.06 days, aroD n = 225 mean lifespan = 20.51 days (P<0.0001), 
aroD + 25 µM PABA n = 127 mean lifespan = 16.20 days (n.s), aroD + 250 µM 
PABA n = 132 mean lifespan = 13.83days (n.s). Data shown is representative from 2 
biological replicates. 
 
 
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
0 10 20 30 40
Survival
Day of adulthood
Control
aroD
aroD + 25 µM PABA
aroD + 250 µM PABA
90 
 
supplementation causing a 13% increase (Log Rank P=0.0107, Wilcoxon P=0.0028), 
and 16 µg/ml SMX supplementation with a similar increase of 16% (Log Rank 
P=0.0002, Wilcoxon P=0.0003) (Figure 17a). On peptone media, only 128 µg/ml 
SMX was supplemented and compared to the control group. 128 µg/ml SMX 
supplementation showed a 46% increase in longevity (P<0.0001) (Figure 17b). 
 
3.2.7 Lifespan analysis with SMX on high purity agar 
Lifespan analysis was also performed with these 3 concentrations of SMX 
supplementation on the high purity agar obtained. On the tryptone media, again 128 
µg/ml supplementation showed the largest increase at 28% (P<0.0001), with 64 µg/ml 
SMX supplementation causing a 25% increase (Log Rank P=0.0029, Wilcoxon 
P<0.0001), and 16 µg/ml SMX supplementation with an increase of 19% (Log Rank 
P=0.0317, Wilcoxon P=0.0003) (Figure 18a). On the peptone based high purity media 
only 128 µg/ml was supplemented and compared to the control. 128 µg/ml 
supplementation showed a 63% increase in longevity (P<0.0001) (Figure 18b). On the 
higher purity agar the longevity increases observed are larger than on the standard 
agar. The lifespan increase induced by SMX treatment supports the preliminary data 
obtained by Andrea, and confirms that SMX treatment increase C. elegans lifespan. 
 
3.2.8 The effect of PABA and folate supplementation on SMX  
In order to investigate whether the longevity increase caused by SMX was folate 
specific, lifespan experiments were performed with 16 µg/ml and 128 µg/ml SMX 
supplementation, and supplementation with PABA. As shown in Figure 19, 
supplementation with PABA at a concentration of 250µM rescued the lifespan 
increase caused by SMX completely. The data also indicated that PABA  
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Figure 17: SMX-treated E. coli extends C. elegans lifespan. C. elegans strain used 
SS104. Control = OP50 E. coli. A) Lifespan analysis performed using peptone media 
and rich agar. Control n = 116 mean lifespan = 13.95 days, 128 µg/ml SMX n = 128 
mean lifespan = 20.30 days (P<0.0001). B) Lifespan analysis performed using 
tryptone media and rich agar, with SMX supplementation at the concentrations stated. 
Control n = 115 mean lifespan = 15.27 days, 16 µg/ml SMX n = 78 mean lifespan = 
17.61 days (P=0.0003), 64 µg/ml SMX n = 113 mean lifespan = 17.31 days 
(P=0.0107), 128 µg/ml SMX n = 102 mean lifespan 19.32 days (P<0.0001).  
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Figure 18 SMX-treated OP50 extends animal lifespan on both tryptone and 
peptone media. C. elegans strain used SS104. Control = OP50 E. coli. A) Lifespan 
analysis performed using tryptone media and high purity agar, with SMX 
supplementation at the concentrations stated. Control n = 132 mean lifespan = 16.53 
days. 16 µg/ml SMX n = 122 mean lifespan = 19.72 days (P=0.0317), 64 µg/ml SMX 
n = 135 mean lifespan = 20.64 days (P=0.0029), 128 µg/ml SMX  n = 152 mean 
lifespan 21.08 days (P<0.0001). B) Lifespan analysis performed using peptone media  
and high purity agar. Control n = 127 mean lifespan = 13.36 days, 128 µg/ml SMX n 
= 129 mean lifespan 21.81 days (P<0.0001).  
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Figure 19: Exogenous folic acid partially rescues the lifespan extension in C. 
elegans maintained on SMX-treated OP50 E. coli. Lifespan analysis performed 
using tryptone media and rich agar, with SMX supplementation and folic acid at the 
concentrations stated. C. elegans strain used SS104. Control = OP50 E. coli. Control 
for A) and B) n = 75 mean lifespan = 14.69 days. A) 16 µg/ml SMX n = 118 mean 
lifespan = 19.74 days (P<0.0001), 16 µg/ml SMX + 500 µM folic acid n = 97 mean 
lifespan = 16.86 days (P=0.0002) B) 128 µg/ml SMX  n = 122 mean lifespan 21.27 
days (P<0.0001), 128 µg/ml SMX + 500 µM folic acid n = 107 mean lifespan = 18.35 
days (P<0.0001). 
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supplementation was not toxic or detrimental to the worm as in the aroD PABA 
rescue lifespan experiment. These data support the hypothesis that the lifespan effect 
caused by SMX is indeed folate specific.  
 
To further investigate whether the SMX was increasing lifespan via a folate specific 
pathway, the low and high concentrations of SMX, 16 µg/ml and 128 µg/ml were used 
for lifespan analysis with high exogenous folic acid supplementation (500 µM), to 
investigate whether the folic acid would rescue lifespan. Lifespans were performed on 
standard (not high purity) agar and tryptone media. Folate supplementation resulted in 
partial rescue of both concentrations of SMX used (Figure 20), similar to the aroD 
mutant E. coli, suggesting that SMX is extending lifespan via a folate specific 
mechanism. 
 
Once it had been confirmed that SMX did indeed increase lifespan in a robust fashion 
independent of media, it was decided that for consistency all further experiments 
would be performed on high purity agar, in order to reduce batch to batch variation, 
with peptone based media.  To determine whether there was a threshold level at which 
the lifespan extension can be observed, or at which it plateaus, a range of SMX 
concentrations from 0.1 µg/ml – 256 µg/ml were used to supplement media in lifespan 
assays. The data shows that SMX supplementation causes the worms live longer, with 
2 µg/ml SMX causing a significant increase in lifespan compared to the control 
(Replicate 1: 14% increase Log rank P<0.0001, Wilcoxon P=0.0005, Replicate 2: 15% 
increase P<0.0001). Concentrations of SMX below 2 µg/ml did increase lifespan, but 
not substantially enough to be statistically significant. A dose of 128 µg/ml SMX 
produced the largest and most robust increase (Replicate 1: 53% increase P<0.0001,  
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Figure 20: A high concentration of PABA supplementation completely rescues 
the increased lifespan of C. elegans maintained on SMX-treated E. coli Lifespan 
analysis performed using peptone media and high purity agar, with SMX and P ABA 
supplementation at the concentrations stated. C. elegans strain used SS104. Control = 
OP50 E. coli. Control n = 102 mean lifespan = 16.70 days. 16 µg/ml SMX n = 176 
mean lifespan = 21.41 days (P<0.0001), 16 µg/ml SMX + 250µM PABA n = 160 
mean lifespan = 16.75 (n.s), 128 µg/ml SMX n = 229 mean lifespan 25.49 days 
(P<0.0001), 128 µg/ml SMX + 250µM PABA n = 217 mean lifespan = 16.05 days  
(n.s). Representative data shown from 2 biological replicates.  
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Replicate 2: 52% increase P<0.0001) (Figure 21).  
 
3.2.9 Both the aroD mutant and SMX treatment extend animal longevity in a 
folate specific manner 
Together with the aroD lifespan data, and in light of the knowledge that man made 
folic acid can contain the breakdown product para-aminobenzoyl-glutamate (PAB-
glu), the data obtained strongly suggest that the extension in lifespan seen was due to 
mutation of aroD in E. coli and the SMX treatment of the E. coli. If this were the case, 
it would lead to the idea that the folate synthesis and folate levels in E. coli are 
important with regards to worm lifespan. In fact it could be hypothesised that neither 
the aroD mutation nor SMX supplementation appear to have any effect in the worm 
itself, but rather in the E. coli, and that the lifespan effect is a result of the worms 
eating this physiologically different E. coli. 
 
3.2.10 C. elegans maintained on SMX resistant OP50 show no lifespan extension 
To test this hypothesis, that the SMX was having an effect mainly on the E. coli 
further lifespan analysis was performed using SMX-resistant OP50. In this study a 
strain of OP50 that had been transformed using a protocol from Prof. John Ward 
(UCL), so that it possessed the R26 plasmid. This OP50 R26 E. coli strain was used 
for lifespan analysis, rather than the standard strain of OP50 usually used. The R26 
plasmid confers resistance to several antibiotics, including sulfonamides as it has a 
drug insensitive allele of dihydropteroate synthase (Stanisich et al. 1976). Data show 
that when C. elegans were maintained on sulfonamide resistant E. coli regardless of 
whether the plates have been supplemented with SMX, there was no lifespan 
extension seen (Figure 22). This result supports the hypothesis that SMX treats, and  
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Figure 21: SMX supplementation results in a dose dependent increase in C. 
elegans lifespan. Lifespans performed on high purity agar and peptone media. C. 
elegans strain used SS104. E. coli strain = OP50 E. coli. Percentage increase in mean 
lifespan as compared to control for 2 replicates are shown. Control n = 102, 191, 0.1 
µg/ml SMX n = 139, 191, 1 µg/ml SMX n = 154, 229, 2 µg/ml SMX n = 152, 210, 4 
µg/ml SMX n = 161, 226, 8 µg/ml SMX n = 146, 224, 16 µg/ml SMX n = 176, 226, 
64 µg/ml SMX n = 235 238, 128 µg/ml SMX n = 229, 230, 256 µg/ml SMX n = 253.  
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Figure 22: SMX treatment does not extend animal longevity in sulfonamide 
resistant E. coli.  Lifespan performed on high purity agar and peptone media. C. 
elegans strain used SS104, E. coli strain OP50 R26 was used, as the R26 plasmid 
confers resistance to sulfonamides. Control n = 215 mean lifespan = 17.11 days, 16 
µg/ml SMX n = 218 mean lifespan = 17.98 days (n.s), 128 µg/ml SMX n = 224 mean 
lifespan = 17.19 days (n.s).  
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has its effect on the E. coli, and it is these treated E. coli that cause a lifespan 
extension in the animal. 
 
3.3 Discussion  
In this chapter I have shown that the aroD mutant E. coli extends worm longevity. 
However, the lifespan effect is variable and sensitive to the type of media being used. 
A more consistent lifespan effect, would allows me to delve further into the 
mechanism behind which this mutant E. coli is increasing lifespan. The targeted 
pharmalogical intervention in the form of SMX that I have applied does extend C. 
elegans lifespan in a more robust, consistent and dose dependent manner, regardless 
of the type of media or agar. I have also shown that the lifespan effect in both aroD 
mutant E. coli and with SMX supplementation appears to be folate specific, and not to 
do with effects on the worm.  The addition of PABA supplementation completely 
rescues the increased longevity induced by both aroD and SMX alike, and 
supplementation with exogenous folic acid partially rescues the extension in lifespan.  
 
Folates are very important for cell growth and repair as well as purine synthesis 
required for DNA and RNA synthesis. In both the aroD mutant and the SMX 
supplementation I am inhibiting the folate cycle of the E. coli but they are still able to 
form a lawn on the plates used for lifespan. Formation of the lawn suggests that even 
with inhibition of folate synthesis, there are sufficient levels of folate for growth. 
Observation of the presence of a lawn by eye is a crude measurement for bacterial 
growth however, and will not detect subtle growth defects.  
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Furthermore C. elegans are unable to synthesise folates themselves and rely on 
microbes for folate uptake. If folate synthesis in the E. coli is inhibited, then the worm 
C. elegans will be taking up less folate. It is possible therefore, that the lifespan effect 
seen in the two systems above is a form of dietary restriction. Whilst performing 
lifespan assays with SMX supplementation, there was a clear difference between 
plates that had SMX supplemented and the control. On the non-supplemented plates 
the worms were evenly distributed over the area of the plate regardless of where the 
lawn was. On the contrary on plates that contained a moderate SMX supplementation 
(a concentration of 2 µg/ml or above), the vast majority of the animals were either in 
the lawn or on the edge of the lawn. The worms appeared to prefer the SMX-treated 
OP50 to normal OP50, which suggests that perhaps it isn‟t a DR effect, at least not in 
the classic sense.  
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CHAPTER 4 
EFFECTS OF SULFAMETHOXAZOLE ON E. COLI AND C. 
ELEGANS  
 
4.1 Introduction 
C. elegans maintained on sulfamethoxazole (SMX)-treated OP50 E. coli show a 
robust increase in lifespan. As described in chapter 3, data suggest that the lifespan 
increase is folate specific, as the extension in longevity can be fully rescued with para-
aminobenzoic acid (PABA) supplementation. The mechanism by which SMX causes 
increased C. elegans longevity, whilst folate dependent, remains unclear. SMX is a 
bacteriocidal antibiotic (Kobayashi et al. 1978; Weening et al. 1983; Yeldandi et al. 
1988) and therefore it may be that SMX prevents E. coli proliferation. If this were so 
then SMX may be working via a dietary restriction mechanism, less food for worms 
results in less folate, and worms depends on E. coli for folates. The inhibition of folate 
synthesis by SMX treatment in the E. coli may also cause growth defects, due to the 
lack of folate species which are required for healthy growth and cell development 
(Bailey & Gregory 1999; Hjortmo et al. 2008; Blatch et al. 2010) 
 
4.1.1 Folate quantification 
The analysis and quantification of folates can be performed using many methods. 
Such methods include microbiological assays, in which folates are quantified by 
measuring the growth of Lactobacillus rhamnous, liquid chromatography (LC), and 
mass spectrometry (Garratt et al. 2005; Lu et al. 2007; Scott et al. 2000; Kwon et al. 
2008a). Coupling LC with mass spectrometry (LC-MS) allows the distinction between 
different folate forms such as dihydrofolate (DHF) or tetrahydrofolate (THF) as 
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described in chapter 1 (Figure 2), resulting in LC-MS becoming a leading tool with 
regards to analysis of folate species (Lu et al. 2007). Further development using LC-
MS, resulted in the ability to detect large numbers of both mono- and polyglutamated 
folates and their molecular precursors present in small amounts of plant material. 
Following these findings, Lu et al. were able to profile the pool of folate species 
present in E. coli using LC-MS(Garratt et al. 2005; Lu et al. 2007; Kwon et al. 2008a).  
 
If sulfamethoxazole (SMX) increases lifespan via dietary restriction (DR), then it is 
possible that there is a trade off in the worm with regards to the longevity increase 
induced when C. elegans are fed E. coli treated with SMX. Thus far, only the lifespan 
of adult worms maintained on SMX-treated E. coli has been observed and not any 
traits earlier in life during development. It may be that an extension in lifespan comes 
at a cost of slow development, as observed with DR. As folates are required for many 
essential processes during development, such as purine synthesis and methionine 
regeneration (Bailey & Gregory 1999; Hjortmo et al. 2008; Blatch et al. 2010), it may 
be that SMX causes deleterious effects on the development and/or reproductive cycle 
of the worm alongside the increase in lifespan. If such a trade off were occurring, then 
whilst C. elegans may live long with SMX supplementation, the health span and thus 
quality of life may be suffering.  
 
4.1.2 Aims and Objectives 
In this chapter I aim to investigate changes in metabolism, in both E. coli and C. 
elegans caused by SMX. In order to provide further information into any metabolic or 
physiological changes caused by SMX supplementation, folate levels wil l be 
measured and quantified using LC-MS, in both worms and E. coli. The folate status of 
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OP50 E. coli and SMX-treated E. coli will be determined, as will the folate levels in 
both C. elegans fed on OP50 E. coli, and those fed on SMX treated OP50. I will also 
use mass spectrometry to investigate changes in folate levels induced by the aroD 
mutant E. coli. I intend to investigate whether the SMX induced lifespan increase in C. 
elegans causes any deleterious effects on growth or fecundity.  
 
4.2 Results 
4.2.1 Folate analysis of aroD E. coli 
In order to be confident that the increase in C. elegans lifespan observed with SMX 
supplementation and the aroD mutant E. coli is caused by a decrease in folate levels 
specifically, together with an international exchange student Nikolin Oberleitner, I 
adopted folate extraction methods from published literature (Garratt et al. 2005; Lu et 
al. 2007) in attempt to quantify folate levels in E. coli. The E. coli folate extraction 
protocol used initially was unable to detect folate species, and therefore Nikolin and I 
adapted the extraction protocol. The new extraction procedure, as described in chapter 
2 (section 2.13.2), was performed on wild type HT115 (DE3) E. coli and the aroD 
mutant E. coli grown on plates at 25°C. The most abundant folate in these bacterial 
samples was formyl- tetrahydrofolate with 3 glutamates (formyl- THFGlu3), in 
previous literature, methyl-tetrahydrofolate with 3 glutamates (methyl- THFGlu3) was 
shown to be the most abundant folate detected (Lu et al. 2007). The resulting 
chromatograms were integrated, and the area under the peak used as a measure of how 
much of a particular folate species was present. To allow comparison between 
different samples, a ratio of amount of folate compared to the amount of Coenzyme A 
(CoA) present was used. It is assumed that CoA is at similar levels across the different 
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samples. My data show that levels of formyl- THFGlu3 are significantly lower in aroD 
E. coli as compared to the wild type HT115(DE3) E. coli (Figure 23). 
 
4.2.2 Folate analysis of C. elegans maintained on aroD E. coli 
The E. coli folate extraction protocol was carried out on C. elegans, however using 
this method, it was not possible to detect many folate species present in the worms. A 
search of the relevant literature revealed that folate extraction in C. elegans had not 
been performed previously. The method for worm folate extraction was optimised by 
a summer student, Gonçalo Correia, and differs from E. coli folate extraction in that 
proteinase K and glass beads are used to aid digestion of the C. elegans (section 
2.13.3). The optimised worm folate extraction protocol was carried out on C. elegans 
maintained on wild type E. coli, and those maintained on the aroD mutant. In these 
worm extraction samples, folate species were detected, the most abundant of which 
was 5-methyl-tetrahydrofolate with 5 glutamates (5m-THFGlu5). To the best of my 
knowledge, folate levels had not been measured in C. elegans previously. Results 
show that levels of 5m-THFGlu5 are significantly lower in C. elegans maintained on 
aroD mutant E. coli, than in C. elegans maintained on wild type E. coli (Figure 24).  
 
These findings confirm that folate levels are decreased in aroD E. coli and in worms 
maintained on aroD E. coli, and therefore it could be that a decrease in folate levels is 
the cause of the lifespan extension observed in C. elegans maintained on aroD E. coli. 
In aroD E. coli, the decrease in folate levels, compared to wild type E. coli is much 
more severe than the decrease in folate levels of worms maintained on aroD E. coli, 
and worms maintained on wild type E. coli. This suggests that even though aroD 
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Figure 23: Levels of formyl-THFGlu3 detected by LC-MS are decreased in the 
aroD mutant E. coli compared to the wild type HT115(DE3). Data shown are from 
two biological replicates on high purity agar and peptone media. B) and C) show the 
formyl-THFGlu3 peak in chromatograms of both replicates for control and aroD 
respectively. Numbers on chromatogram indicate time of elusion in minutes of 
compound.  
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Figure 24: Levels of 5m-THFGlu5 detected by LC-MS are decreased in C. elegans 
maintained on aroD mutant E. coli compared to C. elegans maintained on wild 
type E. coli. Data shown are from two biological replicates on high purity agar and 
peptone media. C. elegans strain used SS104. B) and C) show the 5m-THFGlu5 peak 
in chromatograms of both replicates for animals maintained on control E. coli and 
aroD mutant E. coli respectively. Numbers on chromatogram indicate time of elusion 
in minutes of compound.  
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E. coli have much lower levels of folate than wild type E. coli, worms fed on aroD E. 
coli may be able to store or concentrate the folates obtained from the E. coli, as the 
level of 5m-THFGlu5 shows only a small decrease when compared to those worms 
maintained on wild type E. coli, meaning that the level of folate required from E. coli 
by C. elegans is much lower than is available to them, i.e. E. coli exhibit excessive 
folate synthesis.  
 
4.2.3 Folate analysis of SMX treated E. coli 
To determine whether folate levels are decreased in SMX treated OP50 E. coli, a 
folate analysis was performed on OP50 E. coli (Control) and OP50 E. coli treated with 
128 µg/ml SMX. Several folate species were detected, the most abundant of which 
was formyl-THFGlu3 in concurrence with the most abundant folate in the wild type 
HT115(DE3) strain and the aroD  mutant. Data show, the OP50 strain of E. coli has 
higher levels of formyl-THFGlu3 than the HT115(DE3) wild type strain, respectively 
(Figure 23 and 25). The data show that SMX-treated E. coli show undetectable folate 
levels compared to OP50 control (Figure 25).  
 
4.2.4 Folate analysis of C. elegans maintained on SMX treated E. coli 
Extraction and analysis of worm folates was performed on C. elegans maintained on 
OP50, and on worms maintained on OP50 treated with 128 µg/ml SMX. As before, 
several folate species were detectable, the most abundant folate in these samples was 
5m-THFGlu5 in concurrence with data from worms maintained on HT115(DE3) E. 
coli. Results show that C. elegans maintained on OP50, show similar levels of 5m-
THFGlu5 as worms maintained on the wild type HT115(DE3) E. coli strain. (Figure 2 
and 4). The levels of 5m-THFGlu5 observed in C. elegans maintained on 128 µg/ml 
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SMX treated E. coli, was significantly lower than in C. elegans fed on OP50 (control), 
but detectable unlike the folate levels in E. coli treated with SMX (Figure 26).  
 
The data from the SMX extractions show the same trend as the aroD extractions. In 
SMX treated E. coli, the decrease in folates compared to the control is much greater 
than in C. elegans maintained on SMX treated E. coli, compared to C. elegans fed on 
OP50. This data provide further evidence to support the hypothesis that C. elegans are 
able to store or concentrate the folate obtained from microbes, or obtain folate from 
the medium 
 
This study shows that SMX lowers the level of the most abundant folates more 
dramatically in E. coli than the aroD mutation. This is perhaps expected as aroD is 
further upstream, in the shikimic acid pathway than dihydropteroate synthase (DHPS) 
the enzyme that SMX competes with para-aminobenzoic acid (PABA) for to inhibit 
folate synthesis. This suggests that in the aroD mutant E. coli, there may be 
compensation further downstream in the shikimic acid pathway. For example, small 
amounts of PABA may be obtained by the E. coli from the medium. This small 
amount of PABA may then be fed in to the folate cycle in the aroD mutant E. coli 
which would then help to partially restore the folate level to that of the wild type E. 
coli. SMX however, competes with PABA for DHPS, inhibiting DHPS from aiding 
the reaction in which PABA condenses with dihydropteroate pyrophosphate to 
produce the substrate needed to form dihydrofolate (DHF), as described in chapter 1 
(section 1.9). Due to this specific targeting of folate synthesis, it is expected that SMX 
would decrease the folate levels of E. coli more severely than the aroD mutation.  
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Figure 25: Levels of formyl-THFGlu3 detected by LC-MS are decreased in SMX-
treated OP50 E. coli. Data shown are from two biological replicates on high purity 
agar and peptone media. B) and C) show the formyl-THFGlu3 peak in chromatograms 
of both replicates for control and E. coli treated with 128 µg/ml SMX respectively. 
The level of formyl-THFGlu3 is beyond the limit of detection in SMX treated E. coli. 
Numbers on chromatogram indicate time of elusion in minutes of compound.  
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Figure 26: Levels of 5m-THFGlu5 detected by LC-MS are decreased in C. elegans 
maintained on SMX treated OP50 E. coli. Data shown are from two biological 
replicates on high purity agar and peptone media. C. elegans strain used SS104 B) and 
C) show the 5m-THFGlu5 peak in chromatograms of both replicates for animals 
maintained on control (OP50) E. coli and OP50 E. coli treated with 128 µg/ml SMX 
respectively. Numbers on chromatogram indicate time of elusion in minutes of 
compound.  
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4.2.5 SMX supplementation causes a dose dependent decrease in E. coli folate 
levels 
Previous lifespan data as described in chapter 3 show that SMX causes a dose 
dependent increase in lifespan, with concentrations of 2 µg/ml SMX  and above 
showing a significant increase in lifespan compared to the control. To determine 
whether this increase in lifespan correlated to a dose dependent decrease in folate 
levels, E. coli folate extractions and folate analysis were performed on E. coli that had 
been treated with concentrations of SMX ranging from 0.1 µg/ml – 128 µg/ml SMX. 
The results show that SMX causes a dose dependent decrease in the levels of formyl-  
THFGlu3 until a concentration of 2 µg/ml SMX (Figure 27). In this particular 
experiment, from treatments of 2 µg/ml SMX upwards, the levels of formyl- THFGlu3  
became so decreased, that reliable analysis could not be performed. Thus the folate 
levels of SMX concentrations above 1 µg/ml were noted as below the limit of 
detection.  
 
4.2.6 SMX supplementation causes a dose dependent decrease in C. elegans folate 
levels 
This result coincides with the lifespan data showing that concentrations of SMX from 
2 µg/ml and above, show a significant increase in C. elegans lifespan, suggesting that 
the lifespan increase observed is caused by a change in folate status of the E. coli. 
Extraction and analysis of folates was performed on C. elegans that had been 
maintained on OP50 treated with 0, 1, 4, 16 or 128 µg/ml SMX. Data from this study 
show that at concentrations of SMX above 1 µg/ml the levels of 5m-THFGlu5 are 
severely decreased (Figure 28). In fact, in this instance the levels of 5m-THFGlu5 in 
worms maintained on OP50 treated with 4, 16 or 128 µg/ml are not significantly  
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Figure 27: SMX supplementation causes a dose dependent decrease in E. coli 
OP50 levels of formyl THFGlu3 as detected by LC-MS. Data from two biological 
replicates shown on high purity agar and peptone media. At 2 µg/ml SMX treatment 
levels of formyl THFGlu3 become undetectable.  
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Figure 28: SMX supplementation causes a dose dependent decrease in C. elegans 
5m-THFGlu5 levels as detected by LC-MS. Data shown are from three biological 
replicates on high purity agar and peptone media. C. elegans strain used SS104. 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
different from each other. This data concurs with the E. coli extractions mentioned 
above and the lifespan data from chapter 3, suggesting that the lifespan extension 
observed with SMX treatment correlated to a decrease in E. coli folate levels. 
 
4.2.7 Effects of low folate on development and fecundity of C. elegans 
Having confirmed that SMX treatment significantly decreases folate levels in the E. 
coli and that C. elegans gets its folates from E. coli, I decided to investigate whether 
there were any negative side effects, caused to either the worm or E. coli, by these 
severely decreased folate levels. Folates are essential for nucleic acid synthesis, 
aromatic amino acid synthesis and other one-carbon metabolism including 
methylation and thus for healthy development and growth. A fecundity assay was 
performed on N2 (wild type) C. elegans, maintained on plates that had been 
supplemented with either 0, 16 or 128 µg/ml SMX. In this assay single worms were 
maintained individually on plates, transferred every 24 hours to fresh plates and the 
number of eggs layed each day was counted. Data from this assay show that SMX 
treatment does not alter the time taken for C. elegans to reach the egg laying stage of 
adulthood. Treatment with either 16 or 128 µg/ml SMX does not affect the egg laying 
cycle; eggs are layed at the same time and rate as worms maintained on plates with no 
SMX supplementation (Figure 29a). Treatment with SMX does not have any 
significant effect on total brood size (Figure 29b), however it is important to note that 
the number of eggs layed in self fertilised worms is limited by sperm number. 
Therefore, even though SMX treatment significantly decreases the level of folate in C. 
elegans, worms maintained on SMX treated E. coli, still have sufficient folate levels 
for normal growth and reproduction.  
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4.2.8 Effects of low folate on worm motility 
To further investigate whether SMX might be having any deleterious effects on C. 
elegans, a motility assay was performed on worms maintained on plates with either 0, 
16 or 128 µg/ml SMX supplementation. In this assay I am using motility as a 
biomarker of health. The scoring of motility was performed based on an A,B, C class 
system used by Herndon et al, where animals in class A move constantly leaving 
sinusoidal tracks, animals in class B do not move unless prodded and animals in class 
C exhibit a head or tail twitch when prodded (Herndon et al. 2002). All animals begin 
adulthood with class A motility. Data from this assay show that worms with no SMX 
supplementation remained in class A motility for an average of 8.4 days. C. elegans 
that were kept on plates with 16 µg/ml SMX supplementation showed class A motility 
for significantly longer into adulthood, with a mean of 11.3 days (P<0.0001). C. 
elegans maintained on plates with 128 µg/ml SMX treatment showed the longest 
period with class A motility, an average of 13.2 days (P<0.0001) (Figure 30). These 
data show that SMX does not appear to have any negative effects on worm motility, in 
fact worms treated with SMX remain mobile for significantly longer, suggesting that 
SMX slows ageing. 
 
As SMX supplementation does not appear to have any side effects on the worms, and 
given that the decrease in folate levels is greater in E. coli, we decided to investigate E. 
coli growth rates with regard to SMX treatment. SMX is a bacteriostatic antibiotic, so 
it would be expected that the drug prevents bacterial proliferation. If this was the case 
then it may not be so surprising that the worms maintained on such treated E. coli  
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Figure 29: SMX appears to have no effect on A) development time, egg-laying 
schedule or B) total brood size of N2 worms raised at 25°C. Experiment performed 
on high purity agar and peptone media. E. coli strain used OP50. Control (number of 
animals = 15), 16 μg/ml SMX (n = 18), 128 μg/ml SMX (n = 17). Error bars are ± 
standard deviation  
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Figure 30: C. elegans maintained on SMX-treated E. coli show Class A motility 
for longer throughout adulthood. Experiment performed on high purity agar and 
peptone media. C. elegans strain used SS104. E. coli strain used OP50. Control n = 
130 mean number of days in class A motility = 8.40 days, 16 μg/ml SMX n = 151 
mean number of days in class A motility = 11.34 days, 128 μg/ml SMX n = 145 mean 
number of days in class A motility = 13.21 days.  
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would live longer, due to dietary restriction effects or pathogenic effects from 
proliferation. 
 
4.2.9 Effects of SMX treatment on E. coli growth 
Growth of E. coli both in liquid culture and on NGM plates was investigated. Data 
show that in liquid culture, neither 16 µg/ml SMX nor 128 µg/ml the highest dose of 
SMX used for lifespan extension, significantly affect E. coli proliferation (Figure 31). 
Results from bacterial lawn density on NGM plates, show that SMX has minimal 
effect on E. coli proliferation on agar plates (Control vs. 128 µg/ml SMX P =0.03) 
(Figure 32). To ensure that the E. coli observed in this proliferation assay were viable, 
colony forming unit assays were performed on bacterial lawns from plates with no  
 
SMX supplementation, and bacterial lawns from plates with 128 µg/ml SMX 
supplementation. Kanamycin treatment was used as a negative control due to its anti-
proliferative capacity. Data show that there was no significant difference between 
OP50 proliferation and 128 µg/ml SMX treated OP50 proliferation, confirming that 
the E. coli were proliferating and viable (Figure 33). This result suggests that the 
relatively low dose of SMX used, does not have any apparent negative side effects on 
E. coli growth, in spite of lowering the levels of the most abundant folates 
dramatically.  
 
4.3 Discussion 
In this chapter I have quantified the levels of the most abundant folate - formyl- 
THFGlu3 - in the aroD mutant and E. coli treated with SMX compared to the 
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appropriate controls. The E. coli folate extraction method, has been modified and 
 
 
Figure 31: SMX shows no significant negative effect on OP50 growth in liquid 
culture. Experiment performed in liquid peptone media. E. coli strain used is OP50. 
OD600 measurements of bacterial density taken every 20 minutes show that SMX 
supplementation at 16 and 128 μg/ml has no effect on the log-phase growth rate of 
OP50 in liquid NGM at 37°C. Data shown are mean values from 3 biological 
replicates 
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Figure 32: SMX shows minimal negative effect on OP50 growth on NGM high 
purity agar plates. OD600 measurements of relative bacterial content of established 
lawns from the mean values of 13 plates per condition. Error bars are ± standard 
deviation. Student's t-test values (Control vs. 16 μg/ml SMX: P<0.0001, Control vs. 
128 μg/ml SMX: P=0.032, 16 μg/ml SMX vs. 128 μg/ml SMX: (n.s, P = 0.091)).  
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Figure 33: SMX-treated OP50 show no significant difference in the number of 
colony forming units (CFU) per ml of culture compared to control. Colony 
forming units from bacteria scraped from established lawns on high purity agar plates. 
Student's t-test values (Control vs. 128 μg/ml SMX: n.s, P = 0.26).  
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optimised for use in extraction of C. elegans folates, which has not been carried out 
previously to the best of our knowledge. Following the optimisation process, levels of 
the most abundant folate in worms - 5m-THFGlu5 – have been quantified in C. 
elegans maintained on aroD E. coli, or maintained on SMX treated E. coli and 
compared to the relative controls. These data have shown that SMX is a more 
effective intervention to inhibiting the folate cycle than the aroD  mutation is, as it 
decreases the folate levels in both SMX treated E. coli, and worms kept on SMX 
treated E. coli more dramatically. 
 
Despite the observed decrease in folate levels, observed with SMX supplementation, 
C. elegans development, reproductive cycle or total brood size was not affected. 
However, it remains to be determined whether continued SMX treatment, and  
therefore low folates, had any long term effects. SMX treatment shows a minimal 
effect on E. coli growth, suggesting that SMX is not working via dietary restriction. C. 
elegans appear to have more motility for a longer period on SMX supplemented plates, 
implying that the animals not only live longer but also have an increase health span. 
 
Having confirmed and quantified the folate levels with SMX treatment, we can be 
confident that SMX causes increased C. elegans longevity in a folate dependent 
manner. Levels of the most abundant folates in both worms and E. coli treated with 
SMX supplementation are significantly decreased compared to the controls, which 
might make us question how the E. coli and worms are able to grow and develop 
normally, with such low folate levels.  
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The LC-MS method of detection that we are employing, is able to detect a number of 
folate species. However it is not sensitive enough to be able to detect and quantify all 
folate species present. We are using the most abundant folates, 5m-THFGlu5 and 
formyl- THFGlu3 in worms and E. coli respectively for quantification, to enable us to 
determine whether folate levels are decreased with SMX supplementation. It may be 
possible that while levels of these abundant folates are largely decreased, other folate 
species that we are unable to quantify, are not as dramatically affected. To obtain a 
more complete picture of the level of folate inhibition, and perhaps more insight into 
the pathway via which SMX is causing an increase in lifespan, a more sensitive 
detection method would be required.  
 
In this chapter I have shown that increase in lifespan caused by SMX correlates to a 
decrease in the levels of the most abundant folates. However, whilst this suggests that 
SMX is causing the extension in C. elegans longevity in a folate dependent manner, 
further work is required to uncover the specific mechanism via which SMX is 
working. 
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CHAPTER 5 
THE ROLE OF ANIMAL FOLATES IN LIFESPAN 
DETERMINATION 
 
5.1 Introduction 
5.1.2 Methotrexate 
The drug methotrexate (MTX) was developed in the 1940‟s as an antagonist of folic 
cycle in animals/humans.  At the time of its synthesis it was a unique compound in 
that it was a tightly-binding enzyme inhibitor with a specific target (Chan & Cronstein 
2002; Chabner et al. 1985).  MTX inhibits the enzyme dihydrofolate reductase 
(DHFR), which is essential in the animal folate cycle, to convert dietary folate, DHF 
into THF which is the more biologically useful form of folate. THF is the precursor of 
the active folate forms that are required for synthesis of purines, methionine and serine 
(Chabner et al. 1985). MTX was initially employed as an anti proliferative agent for 
tumour cells, that inhibits purines and pyrimidines for the therapy of malignancies, but 
is now used also for inflammatory diseases such as rheumatoid arthritis (Whittle & 
Hughes 2004; Chan & Cronstein 2002; Chabner et al. 1985). It has been shown that 
100 µg/ml MTX has no effect on wild type animals, but causes nuc-1 worms to 
become sterile, slow developing and uncoordinated (Mello et al. 1991). The nuc-1 
worms lack the nuc-1 nuclease that usually derives purines from the digestion of 
bacteria DNA in the worm gut (Lyon et al. 2000). In normal conditions the folate 
cycle in nuc-1 animals would synthesise the required purines. In the presence of MTX 
however, the folate cycle is also inhibited resulting in the slow growth observed in 
nuc-1 mutants.  
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Having shown that SMX causes its lifespan increase in a folate dependent manner, it 
still remains unclear whether SMX is causing lifespan extension by a direct effect on 
the animal itself, or inhibition of excess folate synthesis in E. coli causing metabolic 
change, and inhibiting a life shortening function in the E. coli. Data presented in 
chapter ,3 regarding sulfonamide resistant E. coli suggest that the lifespan increase is 
due to SMX treatment of the E. coli, as when worms were maintained on SMX treated 
E. coli possessing the R26 plasmid which confers resistance to SMX, no lifespan 
increase in C. elegans was observed. 
 
5.1.3 folt-1 and gcp-2.1 C. elegans mutants 
One of the many advantages of C. elegans as a model system is the availability of 
deletion mutants. A review of the literature and knockout collections flagged folate 
related worm mutants such as folt-1 and gcp-2.1. These mutant worms available from 
the CGC, might enable us to manipulate animal folates independently of E. coli folate. 
As levels of folate are much higher than required for growth in C. elegans maintained 
on E. coli under normal circumstances, it may be possible that reducing the amount of 
excess folate in the animal, may increase animal lifespan.  
 
Folt-1 is one of 3 folate transporters (folt-1, folt-2 and folt-3) in C. elegans 
characterised by Balamuragan et al (Balamurugan et al. 2007; Austin et al. 2010). The 
folt-1homozygous is lethal sterile, and therefore the strain must be maintained as 
heterozygotes. In order for maintenance of this strain a balancer chromosome is used, 
the balancer chromosome is marked with GFP. In folt-1 heterozygous worms the GFP 
is expressed in the pharynx. When folt-1 heterozygotes individuals segregate 
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heterozygous wild type GFP worms, arrested nT1aneuploids (as individuals that are 
homozygous for the balancer chromosome are not viable), and non-GFP homozygous 
folt-1 mutants (Balamurugan et al. 2007). The strain is readily available from the CGC.  
 
Glutamate carboxypeptidase II (GCPII) is an enzyme initially characterized in 
mammals, required to remove glutamate moieties from polyglutamated dietary folate. 
Removal of glutamate molecules, allows uptake of folate species by folate transporters 
that preferentially import monoglutamated folate molecules (Halsted 1998). There are 
three homologues of GCPII in C. elegans, encoded by R57.1 (named gcp-2.1), 
C35C5.2 (named gcp-2.2) and C35C5.11 (named gcp-2.3). gcp-2.1, gcp-2.2, and gcp-
2.3 were named by our group. A review of the literature and my own data from mass 
spectrometry suggests that E. coli contain mainly polyglutamated folates (Kwon et al. 
2008b; Lu et al. 2007), implying the need for a GCPII in C. elegans to allow efficient 
folate uptake. A deletion of the gcp-2.1 gene was available from the CGC. 
 
5.1.4 Aims and Objectives 
In this chapter I aim to look further into the mechanism via which sulfamethoxazole 
(SMX) works to increase animal lifespan. Using folate specific C. elegans mutants 
and other chemical interventions such as MTX, I try to decipher and understand the 
specific pathway within which SMX acts in a folate dependent fashion to extend 
animal lifespan.  
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5.2 Results 
5.2.1 Methotrexate and SMX development assay 
A development assay was performed to determine whether MTX would induce slow 
growth and sterility in worms fed on SMX treated OP50 E. coli. The data show that 
whilst N2 strain C. elegans develop to adulthood normally under all conditions, adults  
appear to produce dead eggs with an apparent decrease in total number of eggs layed 
as MTX concentration is increased in the presence of SMX supplementation. 
Representative images of these observations are shown in Figure 34. This effect has 
been observed to become progressively more pronounced as the dose of MTX is 
increased (from 100 µg/ml to 800 µg/ml). To determine whether inhibition of the 
worm folate cycle using MTX supplementation increased lifespan in a similar manner 
to SMX, lifespan analysis was carried out on C. elegans maintained on OP50 E. coli 
treated with 100 µg/ml MTX, 128 µg/ml SMX, or a combination of both drugs. 
Worms maintained on MTX treated E. coli did not show extended longevity. MTX 
supplementation did not further extend the longevity observed in worms maintained 
on SMX treated E. coli (Figure 35). These data suggest that inhibiting the C. elegans 
folate cycle does not extend lifespan. In order to be certain that the C. elegans folate 
cycle is inhibited by MTX at this concentration, folate levels in C. elegans maintained 
on MTX treated OP50 would need to be confirmed by liquid chromatography coupled 
to mass spectrometry (LC-MS). 
 
5.2.2 folt-1 C .elegans mutant 
The C. elegans mutant folt-1 possesses a deletion in a folate transporter, resulting in 
inhibited folate uptake. As obtained from the CGC, this mutant could not be used for  
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Figure 34: Developmental assay showing C. elegans maintained on E. coli treated 
with both SMX and MTX. High purity and peptone media used. C. elegans strains 
used N2, E. coli strain used OP50. Images taken on day 4 of adulthood. 3 biological 
replicates were performed for each condition, with a representative image shown here. 
Development at 25 °C. On further investigation it was observed that when MTX and 
SMX are combined the eggs layed are dead and do not hatch.  
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Figure 35: MTX does not significantly increase C. elegans lifespan. Lifespan 
analysis performed on peptone high purity agar. C. elegans strains used SS104, E. coli 
strain used OP50. Control n = 303 mean lifespan = 13.09 days, 100 µg/ml MTX n = 
325 mean lifespan = 12.90 days (n.s), 128 µg/ml SMX n = 338 mean lifespan = 20.92 
days (P<0.0001), 128 µg/ml SMX + 100 µg/ml MTX n = 309 mean lifespan = 19.68 
days (P<0.0001). Data shown representative of from two biological replicates. 
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lifespan analysis, as adult homozygous folt-1individuals were sterile and short lived 
(Balamurugan et al. 2007). Many of the mutated worm strains have not been 
outcrossed from the CGC. However outcrossing is important as worm mutants are 
produced using potent mutagens, and therefore it is possible for many mutations to 
occur. Outcrossing limits the number of background mutations present. Therefore we 
attempted to outcross the folt-1 mutant to the N2 wild type C. elegans strain, in order 
to produce a fertile mutant that could be used for lifespan analysis. I hypothesised that 
sterility might be a linked mutation to folt-1. Single worm PCR of 96 worms, 
identified 23 homozygous folt-1 worms, however all 23 were sterile. This result 
confirmed that the sterility phenotype was closely linked to the homozygous folt-1 
mutant, and could not be separated by recombination. (Figure 36). 
 
5.2.3 gcp-2.-1 C. elegans mutant shows a growth defect on SMX 
 Therefore, we turned our attention to the C. elegans gcp-2.1 mutant. In order to 
determine whether folate uptake was impeded in this mutant, a developmenta l assay 
was carried out. The gcp-2.1 mutant animals were healthy and showed normal growth 
on control and 100 µg/ml MTX treated E. coli. Perhaps surprisingly, when compared 
to wild type animals, the gcp-2.1 mutants appeared to show slow development, were 
uncoordinated and sterile on 128 µg/ml treated E. coli. Representative images of these 
observations are shown in Figure 37. This result is consistent with a lack of 
monoglutamated folate species available to the worm from the E. coli; however folate 
levels would need to be confirmed by LC-MS. 
 
 
 
131 
 
 
 
Figure 36: Outcross and genotyping of the folt-1 C. elegans mutant. A) showing 
the GFP tagged pharynx of 2 heterozygous folt-1 individuals (left), and a non-GFP 
expressing folt-1 homozygous individual (right). B) A representative agarose gel 
showing the folt-1 genotype of 32 individual worms as a result of single worm PCR. 
Each lane represents a single worm. Presence of 2 bands indicates a heterozygote. 
Presence of lower band only indicates that the worm is homozygo us for folt-1, 
presence of upper band only indicates homozygous wild type individual  
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Figure 37: Developmental assay showing gcp-2.1 C. elegans maintained on OP50 
E. coli treated with both SMX and MTX.  High purity agar and peptone media used. 
Images taken on day 4 of adulthood. 3 biological replicates were performed for each 
condition, with a representative image shown here. Development at 25 °C   
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5.2.4 Lifespan analysis of gcp-2.1 
Given the observed growth defect of the gcp-2.1 mutant, we assume that the defect is 
caused by the level of useable folates in these worms being decreased. Preliminary 
lifespan analysis was performed to determine whether the decrease of 
monoglutamated folates correlates with an extension in longevity. Results of this 
study show that the gcp-2.1 mutant is significantly longer lived (15.50 days) than the 
wild type control (13.52 days) (P<0.0001) (Figure 38). These preliminary data are 
consistent with the hypothesis that the inhibition of folate uptake in the animal, results 
in a significant increase of C. elegans longevity, folate measurement by LC-MS would 
provide confirmation of these data. 
 
Whilst this data is consistent with our previous hypothesis that removal of excessive 
folate might increase animal lifespan, a review of the strain background showed that 
the mutant had not been outcrossed since being discovered. To confirm that the 
increase in lifespan observed was due to the gcp-2.1 mutant and not perhaps an 
undetected mutation, a summer student, Marta Ciplinski, outcrossed the gcp-2.1 
mutant three times to wild type, and confirmed that the outcrossed gcp-2.1 mutant 
exhibited the same growth defect when maintained on SMX supplemented plates. I 
then used strains of mutant gcp-2.1 and wild type siblings isolated from the most 
recent outcross for further experimentation. A developmental assay was performed 
with the gcp-2.1 mutant and the respective wild type C. elegans maintained on control 
E. coli, 100 µg/ml MTX treated E. coli, and 128 µg/ml SMX treated E. coli. Results 
were consistent with the previous findings, gcp-2.1 mutant C. elegans showed normal 
development on control E. coli, and E. coli treated with 100µg/ml MTX. On E. coli 
that had been supplemented with 128 µg/ml SMX, gcp-2.1 mutant C. elegans  
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Figure 38: gcp-2.1 mutant C. elegans show a significant increase in lifespan. 
Lifespan analysis performed on peptone high purity agar. C. elegans strain used 
RB1055 (gcp-2.1) and N2. E. coli strain used OP50. N2 n = 160 mean lifespan = 
13.52days,  RB1055 (gcp-2.1)  n = 163 mean lifespan = 15.50 days (P<0.0001).  
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appeared to show sterility, uncoordinated movement and slow growth in accordance 
with previous findings. Representative images of these observations are shown in 
Figure 39. Sensitivity of the gcp-2.1 mutant to SMX treated E. coli was rescued by a 
transgene, containing a genomic fragment, including a wild type copy of gcp-2.1 gene 
made by Marta (data not shown).Therefore the growth defect observed is due to the 
gcp-2.1 deletion, we assume that gcp-2.1 decreases folate uptake in the animal, but 
this would have to be confirmed by measuring folate levels using liquid 
chromatography paired with mass spectrometry (LC-MS). 
 
5.2.5 Lifespan analysis of outcrossed gcp-2.1 
Lifespan analysis was performed with newly outcrossed gcp-2.1 mutant and the 
respective wild type control. Before outcrossing, the gcp-2.1 mutant had shown a 
significant increase in longevity compared to N2 wild type strains. After outcrossing, 
the gcp-2.1 mutant lifespan can be compared against the lifespan of a wild type sibling, 
from the same genetic background. Results show that the gcp-2.1 shows no significant 
increase in lifespan with regards to the control or the gcp-2.1 transgenic strain (Figure 
40). Furthermore, we can disregard our previous findings and suggest that inhibiting 
folate uptake in C. elegans does not result in extended longevity, as the outcrossed 
strain of gcp-2.1 does not increase lifespan. Folate measurement by LC-MS would be 
required to confirm this hypothesis.  
 
5.2.6 Folinic acid supplementation rescues the gcp-2.1 growth defect 
As shown, 10 µM folinic acid supplementation was able to fully rescue the growth 
defect observed in gcp-2.1 mutant animals that had been maintained on SMX treated  
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Figure 39: Developmental assay showing growth phenotype of the gcp-2.1 mutant 
C. elegans maintained on SMX treated OP50 E. coli, and rescue with folinic acid. 
High purity agar and peptone media used. C. elegans strain used UF208 (Wild type) 
and UF209. Images taken on day 3 of control adulthood. 3 biological replicates were 
performed, representative images are shown.  
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Figure 40: The gcp-2.1 mutant is not significantly long lived. Lifespan analysis 
performed on peptone high purity agar. C. elegans strains used UF208, (wild type), 
UF209 (gcp-2.1) and UF215 (gcp-2.1+) Control n = 160 mean lifespan = 14.49 days, 
gcp-2.1 mutant n = 167 mean lifespan = 13.44 days (n.s), transgenic (gcp-2.1+) n = 
172 mean lifespan = 12.45 days (n.s).  Data shown are representative from 2 
biological replicates. 
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E. coli. Folinic acid is also known as formyl-tetrahydrofolate monoglutamate, and is 
given as a clinical folate supplement to patients taking MTX, to overcome the 
cytotoxicity and side effects that MTX may have (Chabner et al. 1985; Whittle & 
Hughes 2004). Folic acid, an oxidised monoglutamate folate commonly used as a 
supplement can also be given to people taking MTX. To investigate whether folic acid 
supplementation would rescue the growth phenotype of the gcp-2.1 mutant, worms 
were maintained on SMX-treated E. coli, that had also been supplemented with folic 
or folinic acid. Data show that whilst 10 µM folinic acid fully rescued the growth 
defect in concurrence with previous observations, a concentration of 250 µM folic 
acid was required for a comparable rescue of growth – research carried out by Claire 
Maynard (Figure 41). As described in chapter 3, folic acid is a chemically synthesised 
supplement, at this high concentration, it is possible that there are small amounts of 
the para-aminobenzoyl with a glutamate (PAB-glu) breakdown product, that is taken 
up by E. coli and fed into the folate cycle (Carter et al. 2007). Thus, the growth rescue 
observed in the gcp-2.1 mutant C. elegans at 250 µM folic acid supplementation may 
be due to the PAB-glu restoring the folate status of the E. coli, not the folic acid itself. 
This data suggests that folinic acid is more potent than folic acid, and can restore 
animal folate status back to levels were healthy growth is possible, at relatively low 
concentrations. This is expected as folt-1, 2 and 3 are reduced folate carriers. Folate 
quantification by LC-MS may provide more information. 
 
Since folinic acid is able to rescue the growth defect in gcp-2.1 worms, it shows that it 
can be used as a folate supplement to restore folate levels. This makes us question 
whether folinic acid supplementation, to wild type worms maintained on SMX treated  
E. coli would rescue the extended lifespan induced by SMX supplementation.  
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Figure 41: The growth defect observed in gcp-2.1 mutant C. elegans maintained 
on SMX treated OP50 E. coli, can be rescued with folate supplementation. Data 
obtained and analyzed by Claire Maynard. High purity agar and peptone media used.  
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Lifespan analysis was performed on C. elegans maintained on 128 µg/ml SMX, and 
SMX treated E. coli with either 5 µM or 10 µM folinic acid supplementation. Data 
show that 10 µM folinic acid, the concentration shown to rescue growth defects due to 
decreased folate levels, does not significantly affect the lifespan extension caused by 
SMX supplementation (Figure 42). Surprisingly, 5 µM folinic acid supplementation 
appears to further increase the lifespan extension observed with SMX treatment (SMX 
mean lifespan = 19.31 days, 5 µM folinic acid + SMX mean lifespan = 21.60 days, 
P<0.0001) (Figure 42).  
 
5.3 Discussion 
Here I have used a chemical intervention, in the form of MTX in attempt to inhibit 
folate synthesis in C. elegans, and characterised a C. elegans mutant, that is thought to 
inhibit folate uptake. Results of this study show that neither inhibition of the animal 
folate cycle, nor folate uptake in the animal result in increased longevity. We must 
therefore assume that the folate dependent action resulting in an increase in C. elegans 
lifespan is due to altered folate status in the E. coli, which the worms are fed on. As 
neither folinic acid nor folic acid can be taken up by E. coli, any effects of 
supplementation are purely due to restoring folate levels in C. elegans. I have 
presented data suggesting that folate supplementation, may not affect the lifespan 
enhancing property of E. coli with excess folate removed. Data from 5 µM folinic acid 
show that folate supplementation might further increase the lifespan, however to be 
certain that this effect is real; the experiment would need to be repeated. Perhaps 5 
µM folinic acid is an adequate concentration to partially restore folate levels in the 
worm, but not completely. The growth data of gcp-2.1 indicates that 5 µM folinic acid 
supplementation is not sufficient to rescue growth fully. Maybe an intermediate folate  
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Figure 42: Concentrations of folinic acid that rescue the gcp-2.1 mutant growth 
defect on SMX treated OP50, do not rescue the lifespan increase caused by SMX. 
Lifespan analysis performed on peptone high purity agar. C. elegans strain used 
SS104, E. coli strain used OP50. Control n = 138 mean lifespan = 15.00 days, 128 
µg/ml SMX n = 153 mean lifespan = 19.31 days (P<0.0001), 5 µM folinic acid + 128 
µg/ml SMX n = 171 mean lifespan = 21.60 days (P<0.0001), 10 µM folinic acid + 128 
µg/ml SMX n = 145 mean lifespan = 19.66 days (P<0.0001).  
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status between the low levels induced by SMX, and the excessive levels under normal 
bacterial conditions brings health benefits directly to the animal. Data presented here 
show that folinic acid is a much more potent supplement than the perhaps more 
commonly used folate supplement folic acid, as in this system folinic acid is more 
effective at restoring animal folate levels. Folate measurement by LC-MS would 
provide confirmation of these findings. The human orthologue of folt-1(RFC) absorbs 
mono-glutamated and di-glutamated folate species from the gut. RFC has a much 
higher affinity for folinic acid than folic acid. In humans there are other folate uptake 
systems at work, which in contrast to RFC have a higher affinity for folic acid than 
folinic acid. In C. elegans whilst there are two putative folate transporters; evidence 
suggests that folt-1 is the main transporter. If so, then this could explain why folinic 
acid supplementation shows rescue at much lower concentrations than folic acid, 
because the folt-1 folate transporter preferentially transports folinic acid.  
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CHAPTER 6 
INVESTIGATING THE RELATIONSHIP BETWEEN SMX AND 
KANAMYCIN 
 
6.1 Introduction 
C. elegans in the laboratory are usually fed on established lawns of E. coli. Studies 
have shown that the E. coli must be live and metabolically active to provide the 
required nutrition for healthy growth and development of C. elegans (Lenaerts et al. 
2008). Previous research has shown that when C. elegans are fed dead bacteria, which 
have been killed by antibiotics or UV radiation, the worms exhibit longer lifespan 
(Gems & Riddle 2000; Garigan et al. 2002). There is also evidence to show that the 
variation in C. elegans lifespan increases in liquid, bacteria free, chemically defined 
medium when compared to the lifespan of animals raised on bacterial lawns on plates 
(Szewczyk et al. 2006; Pincus & Slack 2010). These studies imply that whilst C. 
elegans have an essential requirement for live bacteria in order for healthy 
development, the bacteria have a life shortening effect on the worm.  
 
6.1.2 Bacterial accumulation and ageing 
It has been shown that E. coli accumulate in the intestinal lumen of ageing adult C. 
elegans (Garigan et al. 2002; McGee et al. 2011). In this field, there is a common 
assumption that the bacterial accumulation observed in ageing C. elegans is a major 
cause of death. There have been research supporting this model, showing a negative 
correlation between bacterial accumulation level and C. elegans longevity (Baeriswyl 
et al. 2010; Portal-Celhay et al. 2012; Gomez et al. 2012). However, it is worth noting 
that the increase in bacterial accumulation as worms age, may be due to the ageing of 
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the intestine which loses integrity as C. elegans age, and thus may become more 
susceptible to bacterial accumulation (Herndon et al. 2002; Pincus & Slack 2010; 
McGee et al. 2011). As worms progress through adulthood muscle integrity has been 
shown to decrease, leading to a reduction in motility.  Alongside this sarcopenia, it has 
been shown that the pharyngeal contraction rate decreases, which could also lead to 
older C. elegans being more likely to accumulate bacteria in their intestine (Chow et 
al. 2006). Therefore bacterial accumulation may be a biomarker rather than a cause o f 
ageing. 
 
It has been suggested that the antibiotic kanamycin, increases C. elegans lifespan by 
preventing bacterial accumulation in the intestine (Garigan et al. 2002). Kanamycin 
does prevent bacterial proliferation by inhibiting translation (Garigan et al. 2002), 
however to the best of our knowledge it has never been proven that specifically 
preventing bacterial accumulation results in an increased C. elegans lifespan.  
 
In the previous chapter, data show that alterations in microbial folate synthesis, rather 
than C. elegans folate status, cause an increased animal lifespan. It is important to 
note that whilst sulfamethoxazole (SMX) does not slow bacterial growth in this 
system (Figure 31, 32) literature shows that it is an antibiotic. It is possible that 
antibiotic characteristics of the drug may play a role in the robust increase in longevity 
observed in C. elegans maintained on SMX-treated E. coli.  
 
6.1.3 Aims and Objectives 
In this chapter I aim to look further into the mechanism via which SMX works to 
increase animal lifespan. By comparing the SMX-induced increase with a widely 
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accepted mechanism of lifespan extension, such as maintaining C. elegans on 
kanamycin treated E. coli. Secondly I aim to explore whether SMX influences 
bacterial accumulation in the intestinal lumen of C. elegans. 
 
6.2 Results 
6.2.1 Kanamycin and SMX have similar effect on lifespan 
In attempt to provide more information about SMX and the way in which it extends C. 
elegans lifespan, we wanted to compare the increase in lifespan observed with SMX 
treatment to the increased longevity seen when kanamycin treatment is applied to an 
established lawn of E. coli. If SMX supplementation were to further extend the 
increased lifespan seen with kanamycin treatment alone, it would suggest that both 
drugs are working via different pathways. However if when both drugs are combined, 
the increase in animal lifespan is not additive, it implies that both drugs may be 
working via a common mechanism or pathway. Pooled results from four experiments 
show that the increase in lifespan caused by kanamycin treatment is indistinguishable 
from the lifespan extension seen with SMX treated OP50 E. coli. When both drugs 
were combined there was a slight increase of approximately 1 day in mean lifespan 
than with either drug alone (Figure 43). Statistical analysis shows that the difference 
between either drug alone and the combination of both SMX treatment and kanamycin 
treatment is significant (P=0.0008). It is worth noting that statistical analysis was 
performed on data pooled from 4 experiments showing the same trend in data 
resulting in large sample sizes, therefore any perturbations would have a large effect 
on the statistics used. The lifespan curve (Figure 43) shows that the increase in 
lifespan when both drugs are used is minimal as the beginning and end of lifespan is 
very similar. After careful consideration and reviewing the data we assume that there  
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Figure 43: SMX and kanamycin exhibit an identical effect on C. elegans lifespan. 
Lifespan analysis performed on peptone high purity agar. Kanamycin treatment was 
80 µl of 10mM Kanamycin added to the bacterial lawn 2 days after seeding. C. 
elegans strains used SS104, E. coli strains used OP50. Control (OP50) n = 423 mean 
lifespan = 17.78 days, Kanamycin n = 466 mean lifespan = 22.28 days (P<0.0001), 
128 µg/ml SMX n = 469 mean lifespan = 22.29 days (P<0.0001), 128 µg/ml SMX + 
Kanamycin n = 481 mean lifespan = 23.21 days (P<0.0001). Data shown are 
representative from 4 biological replicates.  
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is no additive effect of both drugs. This data is surprising as the non additive effect on 
C. elegans lifespan suggests that both drugs are working via a common mechanism. 
Consistent with this hypothesis, the lifespan extension of either SMX or kanamycin 
alone are almost identical. The question arises, how SMX and kanamycin can be 
working through the same mechanism to extend lifespan, when kanamycin is known 
to prevent proliferation of bacteria, whilst our data has shown that SMX has minimal 
effect on E. coli proliferation on plates (Figure 32) and no effect in liquid culture 
(Figure 31). Perhaps SMX inhibits a particular life-shortening activity of E. coli, if so 
then by blocking proliferation kanamycin might also inhibit the life-shortening 
activity. 
 
6.2.2. Does SMX increase lifespan by preventing E. coli accumulation? 
It has been suggested that kanamycin increases the lifespan of C. elegans by 
preventing bacterial accumulation in the intestinal lumen. Bacterial accumulation is 
thought to be a major cause of animal death via catastrophic bacterial infections as a 
result of tight packing in the accumulated area (Garigan et al. 2002). Given the 
identical effect in lifespan, it may be that SMX treatment extends C. elegans lifespan 
via a similar mode of action, by reducing bacterial accumulation within the lumen of 
the worm. To test this hypothesis, bacterial accumulation assays were performed using 
green fluorescent protein (GFP)-tagged E. coli which allowed us to visualise areas of 
accumulation (see section 2.18).  
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6.2.3 SMX increases GFP expression of OP50-GFP 
When preparing for the bacterial accumulation assays, we observed a striking 
difference in the levels of GFP expression between E. coli that had been treated with 
SMX and control E. coli (Figure 44). To quantify this observation, E. coli lawns were 
grown on SMX supplemented plates, and after 2 days when the lawns had established 
the intensity of GFP expression was measured by taking images of the lawns and 
measuring the intensity (section 2.17). Data show that even at low concentrations such 
as 1 µg/ml SMX, the brightness of GFP observed was substantially higher than 
observed in control E. coli with no SMX supplementation. There was a dose 
dependent increase in GFP intensity. Whilst analysing these plates, we observed that 
as well as an increase in GFP intensity, the edges of the bacterial lawns appeared to 
become smoother with SMX supplementation (Figure 44b). This change in E. coli 
lawn morphology perhaps indicates that the SMX is having a subtle effect on the 
bacteria shape or adhesion, SMX-treatment does cause a change in E. coli cell 
morphology. 
 
We wanted to determine whether this increase in GFP intensity was a characteristic of 
sulphonamides in general, perhaps sulphonamides cause an increase in transcriptional 
response of the E. coli. In order to test this we performed the same bacterial lawn 
assay using GFP-tagged OP50 treated with another sulfonamide, sulfaguanidine 
(SFG). When compared to SMX, SFG showed no significant increase in GFP intensity 
when compared to control, even at the highest dose (Figure 45). Whilst SFG is only 
one of the many sulfonamides, this result does suggest that not all sulfonamides have 
the same effect on transcription, and therefore the increase in GFP intensity observed 
with SMX supplementation is not a general characteristic of all sulfonamides.  
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Figure 44: SMX treatment induces a dose dependent increase in OP50 E. coli 
GFP intensity. High purity agar and peptone media used A) Graph showing 
percentage increase in GFP intensity as compared to the control (no SMX 
supplementation). B) Images of GFP bacterial lawn excluding the edges were used to 
quantify GFP intensity. Data shown are representative from 3 biological replicates.  
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Figure 45: Sulfaguanadine does not induce an increase in OP50 E. coli GFP 
intensity.  High purity agar and peptone media used. Concentrations used 1, 2, 4,8,16, 
64 and 128 µg/ml of each sulfonamide respectively. Percentage increase of GFP 
calculated by comparing mean GFP intensity treated OP50 with base level GFP 
intensity of untreated OP50 E. coli.  
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6.2.4 Assessing bacterial accumulation on our system 
Bacterial accumulation assays were performed, scoring adult C. elegans as either no 
accumulation, partial accumulation or full accumulation (Figure 46). These classes 
were used, as heterogeneity in levels of accumulation was observed and these classes 
allowed the least subjective scoring of individuals.  In these assays only E. coli 
accumulation in the intestinal lumen of the worms was recorded, and bright spots in 
the pharynx area were not included. Scoring of animals was performed using a long 
pass Leica GFP2 filter that allows all long wavelengths through, allowing  a clear 
distinction between E. coli GFP expression (bright green), and autofluorescence 
(which appeared more yellow in colour) (Figure 47). Worms were observed from day 
1 of adulthood for accumulation during these assays. Worms began to accumulate E. 
coli from day 5 of adulthood. Whilst our finding suggest that SMX does not appear to 
prevent bacterial accumulation as kanamycin is reported to, SMX does seem to delay 
the onset of bacterial accumulation (Figure 48). Comparing replicates of the assay 
shows that accumulation patterns are similar between live worms in different 
experiments. 
 
If bacterial accumulation was a major cause of death, it may be expected that there 
would be an increase in accumulation with time, with all worms showing high levels 
of accumulation in the later stages of adulthood, our data shows that the number of 
worms with full accumulation appears to decrease with age. Approximately 40% of 
recently dead worms show no signs of accumulation (Figure 49). 
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Figure 46: Scoring of C. elegans intestinal GFP bacterial accumulation. High 
purity agar and peptone media used. C. elegans strain used SS104; E. coli strain used 
OP50-GFP. Representative images of the 3 classes of accumulation scored in this 
study A) No accumulation, B) Partial accumulation, C) Full accumulation. Images 
taken on day 6 of adulthood.  
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Figure 47: Use of a wide pass filter enables distinction between GFP bacterial 
fluorescence and autofluorescence. Representative images depicting different 
autofluorescence. High purity agar and peptone media used. A) No autofluorescence, 
green observed is GFP bacterial fluorescence, B) Some GFP bacterial fluorescence 
observed (green), most of the worm shows autofluorescence (yellow), C) Two spots of 
yellow autofluorescence in the pharynx region, intermittent with green bacterial 
fluorescence. Images taken on day 6 of adulthood.  
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Figure 48: Levels of GFP bacterial accumulation in the intestinal lumen of live 
worms throughout adult lifespan.  High purity agar and peptone media used. C. 
elegans strain SS104, E. coli strain OP50-GFP. Y axis represents number of worms. 
Representative data from 3 biological replicates are shown.  
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Figure 49: Levels of GFP bacterial accumulation in the intestinal lumen of 
recently dead worms throughout lifespan experiment. High purity agar and 
peptone media used. C. elegans strain SS104, E. coli strain OP50-GFP. Representative 
data from 3 biological replicates are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
265 274
357
154 220
123
49 28
8
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Control 16 µg/ml 
SMX
128 µg/ml 
SMX
Full Accumulation
Partial Accumulation
No Accumulation
156 
 
6.2.5 Bacterial accumulation in this system does not appear to be an early 
predictor of ageing 
Lifespan analysis was performed to further investigate whether bacterial accumulation 
was a predictor of lifespan. C. elegans were grown and then sorted on day 6 of 
adulthood into groups based on the level of bacterial accumulation. For this particular 
lifespan assay, C. elegans with either very low levels of bacterial accumulation or 
very high levels of bacterial accumulation were used. For animals with low levels of 
accumulation, typically accumulation was observed in a small part of the intestine, 
either at the tail end of the animal or at the start of the lumen near the pharynx. 
Animals with high levels of accumulation typically showed full accumulation. These 
low accumulation and high accumulation grouped C. elegans were then maintained on 
plates with or without SMX supplementation. Results show that worms with low 
levels of accumulation did not live significantly longer than worms with higher levels 
of accumulation, consolidating our hypothesis that bacterial accumulation may not be 
a major cause of death in worms. This finding suggests that bacterial accumulation 
may not be an early life predictor of ageing. This data also shows that SMX extends 
lifespan regardless of bacterial accumulation level, suggesting that SMX does not 
work by reducing bacterial accumulation (Figure 50). Unfortunately the numbers of 
animals used in this analysis were slightly lower than usual, particularly in the high 
accumulation groups, as there were very few worms in the populations grown 
showing very high levels of accumulation at the point of lifespan set up – day 6 of 
adulthood. To be more confident in this result, this experiment needs to be repeated.  
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Figure 50: Level of bacterial accumulation does not affect lifespan. Lifespan 
analysis performed on peptone high purity agar. C. elegans strain used SS104; E. coli 
strain used OP50-GFP. Control low accumulation n = 66 mean lifespan = 20.96 days, 
Control high accumulation n = 98 mean lifespan = 20.06 days (n.s), 16 µg/ml SMX 
low accumulation n = 130 mean lifespan = 24.21 days (P<0.0001), 16 µg/ml SMX 
high accumulation n = 65 mean lifespan = 24.31 days (P<0.0001).  
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6.3 Discussion 
Here we have shown that SMX and kanamycin treatment appear to have an identical 
effect on C. elegans lifespan. However when both drugs are combined, there is no 
further increase in lifespan. E. coli accumulation assays with SMX supplementation 
showed that many worms die without any apparent accumulation.  Whilst SMX did 
not prevent bacterial accumulation, it did appear to prolong the onset of bacterial 
accumulation in adult worms leading to the hypothesis that rather than being a cause 
of death, bacterial accumulation may be a bio marker of ageing.  
 
Whilst performing bacterial accumulation assays the observation was made that GFP-
tagged OP50 grown on plates with SMX supplementation appeared brighter than 
control OP50. After reviewing literature we made the assumption that this was due to 
an increase in transcriptional response of the E. coli to SMX, and tested SFG another 
sulfonamide to see whether it had a similar effect. Although SFG did not increase 
GFP intensity, lifespan analysis of was not performed on C. elegans maintained on 
SFG treated E. coli. To provide more information lifespan analysis should be 
performed on SFG supplemented E. coli, folate levels of SFG-treated E. coli should be 
measured, and other sulfonamides could also be investigated.  
 
During our bacterial accumulation assays a wide pass filter was used which allows 
distinction between green GFP expression from the accumulated E. coli, and yellow 
autofluorescence. In previous studies looking at bacterial accumulation, 
autofluorescence has not been overly mentioned. In our research we found that many 
worms showed high levels of autofluorescence shortly before death and for a short 
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time period afterwards. This means that if a narrow pass filter, not able to easily 
distinguish between autofluorescence and GFP-expression was used, this high level of 
autofluorescence may be mistaken for a bacterial infection, with GFP-expressing 
bacteria having infected the entire worm body. 
 
Bacterial accumulation assays were performed using GFP tagged E. coli. As 
mentioned SMX treated E. coli are brighter than control OP50. Whilst this means that 
the increase in brightness simplifies the scoring of accumulation in C. elegans 
maintained on SMX treated E. coli, it means that because of this increase there may be 
a slight bias in our results. In theory the same small number of accumulated E. coli 
would be easier to see in SMX treated condition compared to the control. However it 
remains to be seen whether results would be affected. The accumulation assays were 
performed under optimised lighting conditions, which meant that the GFP-tagged E. 
coli were highly visible whether they were treated with SMX or not. Colony forming 
units (CFU) assays could be performed to determine that the observed bacteria 
correlate with CFU counts. Studies that have performed CFU counts report that they 
use 5 or 10 worms. In this assay, it would be useful to be able to perform CFU counts 
on single worms.  
 
Lifespan analysis of worms with either low levels of bacterial accumulation, or high 
levels of bacterial accumulation on day 6 of adulthood was performed both with and 
without SMX supplementation. Whilst results showed that the worms with high 
accumulation did not live significantly longer than those with low levels of 
accumulation, it is worth noting that worms used for this particular lifespan were 
classed into bacterial accumulation categories (either high or low) on day 6 of 
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adulthood when the lifespan experiment as initially set up. After this the bacterial 
accumulation level was not monitored. As bacterial accumulation can vary from day 
to day especially in the early stages of adulthood, which is when the worms were 
classified by accumulation level, perhaps instead of making the conclusion that 
bacterial accumulation level does not correlate with lifespan, the real conclusion of 
this particular experiment is that accumulation level at day 6 does not have an impact 
on final longevity. Unfortunately the numbers of animals in this analysis were slightly 
lower than usually used in the high accumulation groups, as there were very few of the 
worms in the populations grown showing very high levels of accumulation at the point 
of lifespan set up. Therefore to be more confident in this result it would have to be 
repeated. However, in spite of these doubts, given other data from the bacterial 
accumulation assays we can still conclude that severe bacterial accumulation may not 
be a major cause of death in this system, rather a marker of ageing like motility.  
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CHAPTER 7 
GENERAL DISCUSSION 
 
7.1 Overview of results 
The initial finding leading to this project was the chance discovery and the 
characterisation of the E. coli aroD mutant. When C. elegans were maintained on the 
aroD mutant they show extended lifespan. The aroD gene codes for the enzyme 3-
dehydroquinate dehydrotase, essential in the shikimic acid pathway, the pathway that 
produces chorismate the precursor to all aromatic compounds including folates. 
Supplementation with para-aminobenzoic acid (PABA) completely rescues the 
lifespan extension, suggesting that the aroD mutant E. coli causes its effect on 
lifespan in a folate specific manner. To further investigate this, varying concentrations 
of exogenous folates were supplemented to the media. Folic acid supplementation was 
shown to partially rescue the extended C. elegans lifespan with lower concentrations 
of exogenous folic acid. With high concentrations of folic acid supplementation or 
folinic acid at supplementation, lifespan was not significantly different from the 
control, confirming that the lifespan increase is caused by a folate specific mechanism.  
 
The lifespan effect caused by the aroD mutant was found to be sensitive to 
perturbations in media. The enzyme encoded by aroD, is upstream in the shikimic 
acid from folates, and thus it was possibly that perhaps the mutation in aroD might be 
affecting other processes as well as folate synthesis. Due to these drawbacks of the 
novel mutant, I aimed to find a pharmalogical intervention that more specifically 
targeted folate synthesis, and to determine whether this intervention would cause a 
similar increase in C. elegans lifespan than that observed with aroD mutant E. coli. I 
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focused on the sulfonamide sulfamethoxazole (SMX), which exhibits a dose 
dependent increase in C. elegans lifespan maintained on SMX-treated OP50, without 
being sensitive to media type. The increase in lifespan observed in C. elegans with 
SMX supplementation can also be fully rescued by the addition of PABA, implying 
that the lifespan effect is folate dependent.  
 
To investigate any changes in metabolism with regards to the aroD E. coli mutation 
and SMX treatment, I used liquid chromatography coupled to mass spectrometry (LC-
MS) to measure and quantify folate levels in both E. coli and worms. Folate analysis 
showed that formyl tetreahydrofolate with 3 glutamates (formylTHFGlu3) was the 
most abundant folate species observed in E. coli. The aroD mutant E. coli contained 
significantly lower levels of formylTHFGlu3 than the wild type HT115(DE3) strain. In 
C. elegans the most abundant folate observed using our method of extraction of 
analysis was 5-methyl tetrahydrofolate with 5 glutamtes (5-methylTHFGlu5). Worms 
maintained on aroD mutant E. coli also showed significantly lower levels of 5-
methylTHFGlu5. Folate measurements using SMX treated OP50 showed similar 
patterns to the aroD mutant, significantly lower levels of the most abundant folate 
species in both worms and E. coli. Levels of formylTHFGlu3 in E. coli treated with 
high dose SMX (128 µg/ml) were beyond the limit of detection. Folate analysis of E. 
coli and worms grown on a range of SMX concentrations showed that SMX 
supplementation above 1 µg/ml resulted in the levels of the most abundant folate 
levels in both E. coli and C. elegans being decreased to a level below the limit of 
detection.  
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With such drastic decreases in the levels of folate, it raises the question whether this 
change in folate status has any deleterious side effects on bacterial growth, or C. 
elegans growth and reproduction. SMX supplementation causes a minimal effect on 
bacterial lawn density, but causes no proliferation defec ts. Furthermore, C. elegans 
maintained on SMX treated OP50 show no significant change in development time, 
reproductive cycle or total brood size. To examine whether SMX exhibited any 
negative side effects later in C. elegans life, I used at worm motility as a marker of 
ageing. C. elegans maintained on SMX treated E. coli, show higher levels of motility 
later into adulthood. This result implies that SMX prolongs ageing in worms.  
 
Thus far, data had shown that a change in folate status can cause extended lo ngevity in 
C. elegans. The exact mechanism however remained unclear. The drug methotrexate 
(MTX) was employed as an intervention that would specifically target and inhibit the 
C. elegans folate cycle. MTX did not cause a significant increase in worm lifespan, 
implying that inhibition of the C. elegans folate cycle alone does not extend longevity.  
 
To determine whether impeded folate uptake in the animal would have an effect on 
lifespan we used the gcp-2.1 worm mutant. The gcp-2.1 gene codes for the enzyme 
GCPII which cleaves glutamate molecules from polyglutamated folates. The removal 
of glutamate molecules is essential, as it has been reported that folate transporters 
show higher affinity for monoglutamated folate species. Results showed that gcp-2.1 
mutant worms did not exhibit any significant increase in lifespan, and therefore 
inhibition of folate uptake in the worm does not extend longevity.  
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When gcp-2.1 worms were maintained on SMX treated E. coli they showed stunted 
growth, uncoordinated movement and sterility. This finding provided the first 
phenotype of SMX supplementation other than extended lifespan, and provides 
support for the hypothesis that gcp-2.1 mutant worms have a lack of monoglutamated 
folate species. The growth deficiency observed in gcp-2.1 mutant worms was 
rescuable with folate supplementation. Folinic acid, a monoglutamated form of folate, 
was a more potent supplement than folic acid, illustrated by its ability to restore 
healthy growth at low concentrations (5 and 10 µM), which is expected as the folate 
transporters in C. elegans are reported to be reduced folate carriers. As low 
concentrations of folinic acid supplementation can restore folate status of gcp-2.1 
mutants grown on SMX treated OP50, I investigated whether folinic acid 
supplementation would rescue the lifespan effect caused by SMX. Folinic acid did not 
rescue the increased lifespan observed with SMX supplementation.  
 
Finally the SMX induced increase in lifespan was compared to maintaining worms on 
kanamycin. E. coli treatment with either SMX or kanamycin results in an identical 
increase in C. elegans, with no additive effect on longevity when E. coli are treated 
with both SMX and kanamycin. This data suggests that both kanamycin and SMX are 
working via the same mechanism to increase C. elegans lifespan. It is thought that 
kanamycin causes its effect on lifespan by preventing the accumulation of E. coli in 
the intestinal lumen of ageing C. elegans. Bacterial accumulation assays focussed on 
single worms and followed accumulation throughout adulthood. Data show that 
approximately 40% of worms die with no visible accumulation, and that SMX does 
not prevent E. coli accumulation, but does prevent the onset of accumulation.  
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7.2 Other folate related genes in E. coli also increase C. elegans 
lifespan 
A screen of E. coli mutants and their effect on worm lifespan, performed in our lab 
that two genes involved in folate synthesis, pabA and pabB increased C. elegans 
lifespan significantly. Both pabA and pabB are involved in synthesis of PABA. In E. 
coli, PABA is produced from chorismate in two stages. In the first step, the proteins 
PabA and PabB, coded for by pabA and pabB respectively, interact to catalyze the 
transfer of the amino group from glutamine to chorismate (Green et al. 1996; Basset et 
al. 2004). Interestingly other genes involved in the folate cycle appeared to have no 
effect on C. elegans lifespan, confirming that E. coli folate synthesis not the folate 
cycle is important for lifespan. 
 
7.3 The importance of folate synthesis 
All bacteria require folates for growth and synthesis of essential compounds, however 
not all bacteria have the genes required to synthesize folate. Folate is secreted by 
many bacteria, including E. coli (Iwai et al. 1970; Hoffbrand et al. 1971; Pompei & 
Cordisco 2007), but other bacteria need to import folate – for example some species of 
Lactobacillus (Rossi et al. 2011). A recent study shows that folate synthesis genes are 
highly represented in human gut microbes before the age of two years, but after this 
age show decreased representation, with an increase in the representation of folate 
salvage genes (Yatsunenko et al. 2012).  
 
Methionine is generated from the folate cycle, and is then converted in s-adenosyl 
methionine (SAM), the primary methyl donor used in cells. It has been shown 
previously that methionine restriction causes an increase in lifespan in both rodents 
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and Drosophila. Disruption of C. elegans SAM synthase (SAMS-1) has also been 
shown to increase lifespan (Hansen et al. 2005). Metformin, a drug widely used in the 
treatment of type 2 diabetes has been reported to extend C. elegans lifespan. It has 
been reported that lifespan increase induced by metformin, is in part due to the effects 
of the drug on bacterial folate and methionine metabolism (Cabreiro et al. 2013) 
 
7.4 Sulfa-drugs can effect folate synthesis at two different stages 
During folate synthesis, dihydropteroate synthase catalyzes the condensation of 
dihydropterin pyrophosphate and PABA to form dihydropteroate. Sulfonamide drugs, 
inhibit folate production at this step by competing with PABA, and by acting as a 
substrate for dihydropteroate synthase (DHPS) itself. The resulting sulfa-
dihydropteroate acts as an additional folate inhibitor, competing against dihydrofolate 
(DHF) (Figure 51) (Patel et al. 2004; Nguyen & Clarke 2012). This finding may help 
to explain why SMX-treated E. coli show a more severe decrease in the level of the 
most abundant folate than observed in the aroD mutant E. coli. The aroD mutation is 
broad and directly effects the production of chorismate which produces PABA, which 
is then converted into folate. Literature suggests that E. coli are able to take up PAB-
Glu, which can then be used to feed PABA into folate synthesis. Therefore, in aroD 
mutant E. coli, traces of PAB-Glu obtained from the media would partly restore folate 
synthesis. SMX in contrast directly competes with PABA. Therefore PAB-Glu would 
not restore folate levels as SMX would still compete with PABA. The effect that aroD 
mutant E. coli, or SMX treatment have on C. elegans lifespan is fully rescued with 
high concentrations of PABA supplementation. With PABA supplementation, SMX 
cannot out compete PABA, and this results in less sulfa-dihydropteroate derivative 
being produced, thus blocking SMX at both action points.  
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Figure 51: Sulfa-drugs impact folate synthesis at two different points . Image from 
Nguyen & Clarke, 2012. 
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7.5 A more sensitive method of folate quantification is required 
SMX increases C. elegans lifespan in a dose dependent manner, with a concentration 
of 2 µg/ml, showing a significant and robust increase. Folate analysis shows that 
treatment of E. coli with more than 1 µg/ml SMX decreases the levels of the most 
abundant folates in both E. coli and worms fed on SMX treated E. coli to beyond the 
limit of detection. With such a drastic decrease in folate levels, we would perhaps 
expect the E. coli to exhibit growth defects, however this is not the case. E. coli show 
only a slight decrease in lawn density and no significant change in proliferation, 
suggesting that folate levels are sufficient for normal growth and cell division. In 
order to determine the required folate level for growth a far more sensitive method of 
folate detection would be needed. Perhaps a better folate extraction method could be 
employed, or the current extraction protocols optimised further. It may also be 
possible to further adapt the LC-MS method that I have used throughout this research. 
If the folate detection and quantification was optimised further, then it may provide 
information on changes in levels of other folate species, rather than only the most 
abundant folate species. It may also enable detection of monoglutamated folate 
species, which may be particularly useful for the gcp-2.1 mutant worm.  
 
7.6 How can SMX and kanamycin work via a common mechanism? 
Data presented in chapter 6, indicate that SMX and kanamycin treatment have an 
identical effect on C. elegans lifespan. This is unexpected as SMX treatment does not 
prevent E. coli proliferation, but kanamycin treatment does, so a common mechanism 
seems unlikely. One possible mechanism could be that in E. coli, a folate dependent 
pathway normally produces an unknown life shortening compound. In this theoretical 
model, SMX would directly inhibit the folate dependent process and thus inhibit 
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production of the life shortening compound. In the same manner, by preventing E. coli 
proliferation completely, kanamycin would also inhibit this pathway, and thus the life 
shortening compound would not be produced. It is important to note also that both 
drugs are antibiotics, which may lead one to the hypothesis that it is an antibacterial 
characteristic of these drugs that is causing an increase in animal lifespan. While this 
may be true as not enough is known about the mechanism via which either drug works, 
the evidence presented here is substantial and strongly suggests that the mechanism is 
folate specific (Figure 52).   
 
7.7 Application to mammals 
Data presented in this thesis suggest that inhibition of E. coli folate synthesis slows 
animal ageing without any apparent negative effects on the animal or E. coli growth. 
Therefore this type of intervention to target folate synthesis may be possible in the 
mammalian gut, without causing significant disruption to the gut microbiome. 
However, different species of bacteria would need to be tested, due to diversity of 
microbiota present in the gut. Since SMX is an antibiotic it may kill other species of 
bacteria. Also SMX treatment on a mixture of microbes representative of the gut could 
be performed, to determine whether the composition of gut microbiota would change. 
As described in chapter 1, even with varying composition between individuals, it has 
been shown that prevalence of certain bacterial species can infer a higher risk of 
disease. If SMX promoted prevalence of such a species it would not be wise to use as 
an intervention.  Research into the effect of sulfonamides on rodents was performed in 
the 1950‟s and 1960‟s. Results show that both rats and mice lived longer when given 
sulfadiazine (Hackmann 1958). Furthermore, in agreement with my findings, the 
lifespan increase observed by Hackmann was rescued with PABA supplementation.  
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Figure 52: Potential model in which SMX and kanamycin inhibit production of a life 
shortening compound (denoted by “?”) normally produced in E. coli 
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This implies that it is possible to target microbial folate synthesis using sulfonamides 
in mammals, with a beneficial effect on health. Since data here suggest that inhibition 
of bacterial folate is the key determinant in lifespan extension, then perhaps other 
sulfonamide drugs, or alternative drugs that lower folate could be researched into. As 
some sulfonamides are not absorbed by humans, such a drug would be ideal as it 
would mean that any side effects to the human host would be minimal, whilst gaining 
the health benefit of treating gut bacteria and reducing their folate synthesis. As data 
suggests chapter 5 shows, if SMX were to be used in humans, folinic acid could also 
be taken to ensure that human folate levels were not deficient as a side effect of gut 
microbiota, one of our sources of folates, having inhibited folate synthesis.  
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